Podcasts about World Health Organization

IDPH will now be able to form guidelines using a combination of the CDC's guidance, recommendations from the World Health Organization and other medical and scientific disease prevention experts — and require that immunizations recommended by the state be covered by state-regulated insurance plans.

In today's episode, I'm opening the first chapter of what I believe is the most important series I've ever created — a deep dive into progesterone and why it became the heart of my medical practice. For more than 20 years, I've watched this “simple, humble hormone” transform women's lives in ways most conventional medicine overlooks. What started in two small treatment rooms has grown into a 25,000 sq ft facility, and the core of our success comes down to understanding progesterone's impact on the female brain, stress response, and emotional resilience. In this episode, I break down: Why progesterone is far more than a reproductive hormone How it regulates the female stress response (amygdala, hippocampus, prefrontal cortex) Why anxiety, insomnia, irritability, and emotional overwhelm often map directly to progesterone decline Why so many women feel “unraveled” in their 40s — and why it's not their fault The science behind oral vs. sublingual progesterone (and why I use troches) How conventional medicine often misses the root cause The importance of physicians showing their work, their data, and their citations The lived stories and clinical outcomes that changed how I practice medicine If you've ever felt dismissed, unseen, or told that your anxiety or mood changes are “just stress,” this episode is for you. This is the beginning of a 7-part series where I break down the neurobiology, endocrinology, testing, dosing, delivery methods, breast health, perimenopause, and more.   Citations: Brinton, Roberta Diaz, et al. “Neurosteroids and Brain Function.” Steroids, vol. 81, 2014, pp. 61–78. Epperson, C. Neill, et al. “New Insights into Perimenopausal Depression: A Neuroendocrine Vulnerability Framework.” The Lancet Psychiatry, vol. 9, no. 2, 2022, pp. 110–118. Frye, Cheryl A. “Neurosteroids—Endogenous Modulators of GABA_A Receptors.” Pharmacology & Therapeutics, vol. 116, no. 1, 2007, pp. 58–76. Genazzani, Andrea R., et al. “Progesterone, Stress, and the Brain.” Human Reproduction Update, vol. 16, no. 6, 2010, pp. 641–655. Meeker, John D., et al. “Environmental Endocrine Disruptors: Their Effects on Human Reproduction and Development.” Reproductive Toxicology, vol. 25, 2008, pp. 1–7. Mellon, Stanley H. “Neurosteroid Regulation of Central Nervous System Development.” Pharmacology & Therapeutics, vol. 116, 2007, pp. 107–124. Mizrahi, Romy, et al. “The Role of Allopregnanolone in Stress, Mood, and Trauma.” Neurobiology of Stress, vol. 11, 2019, 100198. Paul, Steven M., and Graziano Pinna. “Allopregnanolone: From Molecular Pathways to Therapeutic Applications.” Current Opinion in Neurobiology, vol. 48, 2018, pp. 90–96. Pluchino, Nicoletta, et al. “Progesterone and Allopregnanolone: Effects on the Central Nervous System in the Luteal Phase and in Perimenopause.” Gynecological Endocrinology, vol. 36, no. 6, 2020, pp. 441–445. Rasgon, Natalie L., et al. “Perimenopausal Changes in the Brain and Mood: A Review.” Journal of Clinical Endocrinology and Metabolism, vol. 107, no. 4, 2022, pp. 1120–1134. Reddy, Doodipala Samba. “The Neurosteroid Allopregnanolone and GABA-A Receptor Modulation in Epilepsy and Mood Disorders.” Frontiers in Neuroscience, vol. 12, 2018, 933. Schiller, Crystal E., et al. “The Neuroendocrinology of Perimenopausal Depression.” Trends in Neurosciences, vol. 44, no. 2, 2021, pp. 119–135. Schumacher, Michael, et al. “Neuroprotective Effects of Progesterone and Its Metabolites.” Frontiers in Neuroendocrinology, vol. 33, 2012, pp. 415–439. Selye, Hans. “The General Adaptation Syndrome and the Diseases of Adaptation.” Journal of Clinical Endocrinology, vol. 6, no. 2, 1946, pp. 117–230. Sheng, Jun, and György Buzsáki. “Neuronal Firing and Theta Oscillations in the Amygdala During Fear Conditioning.” Neuron, vol. 53, 2007, pp. 653–667. Smith, Sheryl S. “Progesterone Withdrawal Increases Neuronal Excitability in the Hippocampus: A GABA_A Mechanism.” Journal of Neuroscience, vol. 28, 2008, pp. 10171–10179. Snyder, Jonathan S., et al. “Adult Hippocampal Neurogenesis and Stress Regulation.” Nature Reviews Neuroscience, vol. 12, 2011, pp. 1–9. Stanczyk, Frank Z., and Jerilynn C. Prior. “Progesterone and Progestins: A Review of Pharmacology, PK, and Clinical Use.” Steroids, vol. 82, 2014, pp. 1–8. Tu, Ming-Je, et al. “Oral, Vaginal, and Transdermal Progesterone: PK, Metabolism, and Tissue Distribution.” Drug Metabolism Reviews, vol. 52, no. 2, 2020, pp. 1–28. Wang, Jun, et al. “Stress, Amygdala Plasticity, and the Neuroendocrine Interface.” Nature Neuroscience, vol. 10, 2007, pp. 1093–1100. Weinstock, Marta. “The Hippocampus and Chronic Stress.” Neurochemical Research, vol. 42, 2017, pp. 1–12. World Health Organization. Progesterone and Reproductive Function: Clinical Perspectives. WHO, 2019.   Dr. Brendan McCarthy is the founder and Chief Medical Officer of Protea Medical Center in Arizona. With over two decades of experience, he's helped thousands of patients navigate hormonal imbalances using bioidentical HRT, nutrition, and root-cause medicine. He's also taught and mentored other physicians on integrative approaches to hormone therapy, weight loss, fertility, and more. If you're ready to take your health seriously, this podcast is a great place to start.  

Want to listen to this episode ad-free? Visit our Patreon! Welcome true believers to X-Men Horoscopes where each week our host Lodro Rinzler is in conversation with a special guest to discuss the X-Men issue that aligns with a significant month and year from their life and what that issue reveals about their future. With us this week is threepeat guest Cassandra Smith back to talk about the X-Men and trans rights as we explore the Uncanny X-Men Issue (13) that came out the month the World Health Organization ruled that being transgender is not a mental disorder. What does a ragtag team of misfit X-Men hiding in a bar and hunting their old enemies have to say about the future of trans rights? Geez. This one is tough. Also in this episode:  Rahne is in her sexy era Cyclops tea bags X-Men villains Putting underwear on over your clothes Havok is bored because all of his friends are dead Lodro is upset by Cyclops' sartorial choices Don't shave the hair off my Barbie! None of the X-Men in this era have hobbies Cyclops sleeps in a single bed What does this Dark Beast-laden issue mean for the future of marginalized communities in these dark times? Tune in to find out!     Cassie Smith is a truly creative person, having trained as an actress, most notably at the celebrated National Youth Theatre of London, who has also successfully dabbled in modeling and voiceover work before settling into her skills as a writer, with her first article published in 2021 detailing her perspective as a transgender girl in the modern world. She is an activist at heart, a champion for LGBTQ rights and the fight against racism, lending her voice as an educational public speaker, shedding light on the history and facts surrounding the culture war on trans people. As an avid comic book reader from an early age, Cassie is considered a “go-to” girl when it comes to comics. This lends perfectly to her super fun content coverage as a bubbly Tiktoker and across social media, diving into nerd culture, comic book characters, history and lore! You can find her on Instagram, TikTok and on her monthly publication at Substack.   More of Lodro Rinzler's work can be found here and here and you can follow the podcast on Instagram at xmenpanelsdaily where we post X-Men comic panels...daily. Have a question or comment for a future episode? Reach out at xmenhoroscopes.com   Want to listen to these episodes early/ad-free and get your own X-Men Horoscope read/an awesome t-shirt? Check out our brand-new patreon! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Practice ownership comes with a unique paradox: the autonomy you fought for also means carrying the full weight of clinical work, business management, and leadership. In this episode, Tracy breaks down the World Health Organization's three-phase burnout framework and reveals why nearly half of all physicians are experiencing burnout symptoms—and what makes practice owner burnout distinctly different and dangerous.  Click here for full show notes  Is your practice growth-ready? See Where Your Practice Stands: Take our Practice Growth Readiness Assessment  Episode Highlights  The WHO's three phases of burnout: exhaustion, cynicism, and reduced professional efficacy—and why recognizing which phase you're in determines what help you need  Why American culture makes Phase 1 exhaustion nearly impossible to recognize (hint: we've been conditioned to see depletion as a badge of honor)  The shocking global statistics: from 43% burnout rates in the US to 66% emotional exhaustion among Portuguese physicians  Why practice owner burnout can't be solved with employed physician solutions—you can't "delegate up" when you ARE the up  Real examples of what each phase looks like: from sitting in your driveway without energy to enter your home, to thinking cynical thoughts that horrify you  The $4.6 billion annual cost of physician burnout to the US healthcare system—and the incalculable personal cost to you, your practice, and your family  Why autonomy alone isn't enough: the protection it provides versus the isolation and weight it creates  Memorable Quotes  "Burnout is not a personal failing. It's a predictable occupational phenomenon with identifiable phases."  "Phase one exhaustion is your prevention opportunity. This is where you still have an easy exit ramp. If you catch yourself and actually address it—not by doubling down, but by making strategic changes—prevention strategies actually work."  "You can't think your way out of cynicism using the same thinking that got you there."  "Your practice will survive a few weeks without you, but you might not survive continuing to push through phase three."  "When you're the owner, you can't just leave. Your practice is your livelihood, your investment, and your legacy."  "You are not broken. You are not weak. You are responding predictably to chronic stress that hasn't been successfully managed."  Closing  Understanding burnout isn't about labeling yourself—it's about getting clear on what level of support you actually need. Whether you're in the prevention zone, need intervention, or are facing a crisis, there's a path forward. Join us next episode as we dive into the strategic prevention approaches that work specifically for independent practice owners.  Tracy's Bio:  Tracy Cherpeski, MBA, MA, CPSC (she/her/hers) is the Founder of Tracy Cherpeski International and Thriving Practice Community. As a Business Consultant and Executive Coach, Tracy helps healthcare practice owners scale their businesses without sacrificing wellbeing. Through strategic planning, leadership development, and mindset mastery, she empowers clients to reclaim their time and reach their potential. Based in Chapel Hill, NC, Tracy serves clients worldwide and is the Executive Producer and Host of the Thriving Practice podcast. Her guiding philosophy: Survival is not enough; life is meant to be celebrated.  Connect With Us:  Be a Guest on the Show  Thriving Practice Community  Schedule Strategy Session with Tracy  Tracy's LinkedIn  Business LinkedIn Page 

After months of fighting, the Kremlin says Russian forces have seized the frontline city of Pokrovsk in eastern Ukraine. It links several other key cities in the Donetsk region. Last month, Ukraine sent reinforcements to try to fend off the Russian attack. Kyiv has not acknowledged the loss of the city. Also: the White House defends Defence Secretary Pete Hegseth over US military action off the coast of Venezuela; the presidential election result in Honduras is too close to call; the World Health Organization calls for weight loss jabs to be more widely available; what Australian teenagers make of an up-coming social media ban; the eighty-five-kilometre long traffic jam in Siberia; and an interview with the Taiwanese director who shot a critically-acclaimed film on iPhones.The Global News Podcast brings you the breaking news you need to hear, as it happens. Listen for the latest headlines and current affairs from around the world. Politics, economics, climate, business, technology, health – we cover it all with expert analysis and insight. Get the news that matters, delivered twice a day on weekdays and daily at weekends, plus special bonus episodes reacting to urgent breaking stories. Follow or subscribe now and never miss a moment. Get in touch: globalpodcast@bbc.co.uk

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about what you can take to combat the common cold, the World Health Organization issuing the first-ever guidelines for use of GLP-1 weight loss medications, and what you can do to protect yourself from Norovirus.

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about what you can take to combat the common cold, the World Health Organization issuing the first-ever guidelines for use of GLP-1 weight loss medications, and what you can do to protect yourself from Norovirus.

Weight loss drugs have once again dominated health headlines.The World Health Organization has endorsed Ozempic-type drugs for long-term obesity treatment, while Australia's TGA has issues new safety alerts - so what's going on here? Plus, we dive into the contentious Oxford Word of the Year, and why it was some people raging... literally. And in headlines today, A suppression order has been lifted allowing reporting on the dark history of Greg Lynn; Disgraced former political staffer Bruce Lehrmann will learn today whether a an appeal to overturn a court ruling he probably raped colleague Brittany Higgins is successful; Palestinian militant group Hamas says it is handing over the remains of one of the two last hostage bodies still in the Gaza Strip; The Prada Group has officially purchased Milan fashion rival Versace in a 1.25 billion euro ($A2.21 billion) deal; Miley Cyrus is engaged to musician Maxx Morando THE END BITS Support independent women's media Check out The Quicky Instagram here GET IN TOUCHShare your story, feedback, or dilemma! Send us a voice note or email us at thequicky@mamamia.com.au CREDITS Hosts: Taylah Strano & Claire Murphy Guests: Dr Terri-Lynne South, Chair of RACGP Specific Interests Obesity ManagementMyf Warhurst, cultural commentator & host of The Moment podcast Audio Producer: Lu Hill Become a Mamamia subscriber: https://www.mamamia.com.au/subscribeSee omnystudio.com/listener for privacy information.

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about what you can take to combat the common cold, the World Health Organization issuing the first-ever guidelines for use of GLP-1 weight loss medications, and what you can do to protect yourself from Norovirus.

Walking is something we all do every day, but did you know it has numerous health benefits? It's not just a simple way to get from point A to point B; walking can improve cardiovascular health, boost your mood, and even enhance your overall well-being. According to specialists, it can also help you lose weight under certain conditions. By incorporating regular, brisk walks into your routine, you can take advantage of these benefits and work towards your weight loss goals. First, you need to walk enough. The World Health Organization (WHO) recommends at least 10,000 steps a day to stay fit and maintain a stable weight. But if your goal is to lose weight, you'll need to walk more and at a higher intensity. To really shed those pounds, aim to walk at least three times a week for an hour or more at a brisk pace (between 6 and 8 km/h) and maintain a heart rate between 135 and 160 beats per minute. So, what are those conditions? Is that enough to lose weight? Is one type of walking more effective than another? In under 3 minutes, we answer your questions! To listen to the last episodes, you can click here: ⁠What is the 10-10-10 method for dealing with everyday worries?⁠ ⁠Why has astrology come back into fashion?⁠ ⁠What are the most addictive foods?⁠ A podcast written and realised by Amber Minogue. First Broadcast : 4/9/2024 Learn more about your ad choices. Visit megaphone.fm/adchoices

Tonight on The Huddle host of Q&A and Saturday Mornings Jake Tame and Iron Duke Partners managing director Phil O'Reilly joined in on a discussion about the following issues of the day - and more! New South Wales is considering a plan to halve the power and top speed of e-bikes after a rider died in a collision with a garbage truck. Are e-bikes and e-scooters too fast? The World Health Organization officially backs Ozempic and says it should be made affordable. Should we publicly fund Ozempic? And they revisit the local government rates cap after letting the idea sit for 24-hours. LISTEN ABOVESee omnystudio.com/listener for privacy information.

Welcome back to Ozempic Weightloss Unlocked, the podcast where we break down the latest developments in weight loss medications and what they mean for your health. I'm your host, and today we're diving into some significant news that just dropped.Just yesterday, the World Health Organization released a major guideline on Glucagon-like Peptide-1 therapies, commonly known as GLP-1 drugs like Ozempic and Wegovy. This is a big deal. The WHO is now recommending that adults living with obesity can use long-term GLP-1 therapies for weight management. This conditional recommendation comes with moderate-certainty evidence showing these drugs are effective at achieving meaningful weight loss and providing broad metabolic benefits.But here's what's interesting: the WHO isn't just saying take the medication and you're done. They're emphasizing that people prescribed these drugs benefit significantly from structured behavioral therapy. This includes goal setting for physical activity and diet, energy intake restriction, regular counseling sessions, and ongoing progress assessment. So it's not just a pill and forget it approach. You need the full package.Now, many of our listeners are probably wondering about something that's been trending lately: muscle loss. And this is important. Research shows that rapid weight loss from these medications can decrease your overall muscle mass. But here's the good news: this isn't caused by the drug itself. It's related to the process of losing weight. The key to managing this is focusing on protein intake, staying hydrated, and engaging in strength training. In fact, consistent strength training can lead to improvements in muscle growth within two to three months.Experts recommend eating between 0.8 and 1 gram of protein for each kilogram of body weight daily. And if you're losing weight on a GLP-1 medication, a registered dietitian can help you dial in exactly what you need. Researchers are also actively working on new medications that could preserve muscle mass while you're losing fat, so we may see even better solutions down the road.The bigger picture here is that obesity affects more than one billion people worldwide, and for the first time, we're seeing a reduction in obesity rates in the United States, largely thanks to these medications and people's commitment to using them responsibly.Thank you for tuning in to Ozempic Weightloss Unlocked. Make sure you subscribe so you don't miss our next episode where we'll explore more of the latest breakthroughs in weight loss science. This has been a quiet please production, for more check out quiet please dot ai. Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

Bongani Bingwa speaks to Jeanette Hunter, Deputy Director-General for Primary Health Care at the National Department of Health, about South Africa’s alarming obesity crisis. According to last year’s National Food and Nutrition Security Survey, 31% of men and a staggering 68% of women in the country are overweight or obese. This landscape may soon shift, with the World Health Organization having just released its first guideline on the use of GLP-1 therapies for obesity, conditionally recommending them as part of long-term treatment for a condition that now affects more than 1 billion people worldwide. 702 Breakfast with Bongani Bingwa is broadcast on 702, a Johannesburg based talk radio station. Bongani makes sense of the news, interviews the key newsmakers of the day, and holds those in power to account on your behalf. The team bring you all you need to know to start your day Thank you for listening to a podcast from 702 Breakfast with Bongani Bingwa Listen live on Primedia+ weekdays from 06:00 and 09:00 (SA Time) to Breakfast with Bongani Bingwa broadcast on 702: https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/36edSLV or find all the catch-up podcasts here https://buff.ly/zEcM35T Subscribe to the 702 Daily and Weekly Newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702See omnystudio.com/listener for privacy information.

The World Health Organization is officially recommending GLP-1 drugs for obesity, reshaping the global weight-loss conversation. Plus, we break down the Pizza Economy — how rising prices are influencing what people order, which toppings are getting cut, and why your favorite slice might be pricier next month. Smart takes, sharp laughs, and all the news you didn’t realize you needed.See omnystudio.com/listener for privacy information.

The head of the Office for Budget Responsibility, Richard Hughes, has resigned after his organisation released details of the budget before the Chancellor had delivered her speech. Also: The Prime Minister has denied that the Rachel Reeves misled people about the state of the public finances. And the World Health Organisation calls for fairer access to weight loss jabs.

Monday is World AIDS Day, but the United States government is sitting out the commemoration this year. The World Health Organization created the day in the 1980s to remember those lost to the disease and rally support for prevention and treatment. This is the first year since 1993 that the President of the United States has not signed a proclamation to recognize the day. The Trump Administration also told federal employees not to use government funds or social media for World AIDS Day, according to the New York Times. Matt Toburen leads the Aliveness Project, which supports people living with HIV in the Twin Cities. He joined Minnesota Now host Nina Moini to talk about how his organization is still raising awareness.

Algoma Steel is laying off about a thousand workers — roughly a third of its workforce. The company is pointing to the effects of U.S. tariffs. But it also had government help: half a billion dollars that was supposed to keep workers on the job.And: A fire has been burning through a Toronto highrise complex for more than four days now. But no one can see it. It's smouldering between the concrete walls of two connected buildings, posing an especially complex challenge to firefighters.Also: For the first time, the World Health Organization is recommending GLP-1 drugs like Ozempic as a treatment for obesity. It's a condition that affects millions, and costs billions. But how much medications can help will depend in part on who can get access.Plus: Officials in Manitoba begin another painstaking search in another landfill for the remains of two Indigenous women, the Trump administration faces accusations of war crimes in connection to strikes on an alleged Caribbean drug boat, and more.

CBS Reporter Brad Gibson explains the new rules for doctors set out by the World Health Organization as GLP-1 drugs are becoming easier to obtain. With Megan Lynch.

Opposition leader, Chris Hipkins spoke to Morning Report; The mother of a girl who ate a potentially mouldy school meal is disgusted students were served gone off food; The World Health Organisation has updated its guidelines for their treatment of obesity - and is now recommending GLP-1 drugs, like Ozempic and Wegovy, alongside behavioral therapy; With the country set to miss its Smokefree 2025 target, the government is exploring legalising oral nicotine pouches; For today only, registered charities or schools donated to via Givealittle will receive the full amount, with the crowdfunding site waiving its usual 5% fee.

The World Health Organisation has updated its guidelines for their treatment of obesity - and is now recommending GLP-1 drugs, like Ozempic and Wegovy, alongside behavioral therapy. University of Auckland's Professor Peter Shepherd spoke to Ingrid Hipkiss.

작성자: 최정윤, Tannith KrielWhat drove Korea's school meal workers out of the kitchen?기사 요약: 학교 급식실 노동자들이 파업에 나서 학생들이 대체식을 먹는 가운데, 노동자들은 낮은 임금과 강도 높은 업무가 자신들의 건강까지 위협하고 있다고 주장했다.[1] School cooks and other nonregular school staff began a nationwide walkout last week, calling for improved wages, pay during school breaks and better welfare. But the workers say these demands, while important, only skim the surface of what pushed thousands to walk out of Korea's schools.walkout: 파업 (=strike)A walkout is a spontaneous or planned protest where workers leave their jobs together, while a strike is a more formal, organized work stoppage, often with a specific union vote and no set end dateskim: 훑어보다, 표면을 스치다[2] The school staff strike has been sparked by a deeper crisis, they say — one shaped by toxic working environments that treat the workers responsible for feeding Korea's children as second-class citizens.treat: 어떤 태도로 대하다, 대접하다 / 선물, 간식[3] The workers say they have suffered years of breathing carcinogenic fumes, fainting in overheated kitchens, returning to work with lingering injuries and watching coworkers fall ill, sometimes fatally.carcinogenic: 발암성의, 암을 유발하는faint: 기절하다lingering: 오래 끄는, 사라지지 않는[4] They cite the case of a Seoul school cafeteria worker in her 50s, who learned she had lung cancer in 2023 after a CT scan. Doctors suggested it was caused by cooking fumes generated during frying and high-heat food preparation. The World Health Organization classifies these cooking emissions as probably carcinogenic.cite: 예를 들다기사 원문: https://www.koreaherald.com/article/10622632

This episode of The New Abnormal podcast features Velislava Petrova, Chief Programme Officer at the Centre for Future Generations. She oversees CFG's technical and cross-cutting programs, monitoring impact, aligning with political priorities and identifying strategic directions. Velisalva is also an ex-Senior Policy Consultant with the World Health Organization, Deputy Minister of Foreign Affairs of the Republic of Bulgaria, Senior Manager at Gavi Vaccine Alliance, and a Disaster Risk Management Specialist with the World Bank. We discuss all the above and more in what I found to be a deeply interesting discussion - and I hope you enjoy listening to her views as much as I did.

In this episode of Crazy Wisdom, I, Stewart Alsop, sit down with Argentine artist Mathilda Martin to explore the intimate connection between creativity, flow, and authenticity—from how swimming mirrors painting, to why art can heal, and what makes human-made art irreplaceable in the age of AI. We also touch on Argentina's vibrant art scene, the shift in the art world after COVID, and the fine line between commercial and soulful creation. You can find Mathilda's work on Instagram at @arte_mathilda.Check out this GPT we trained on the conversationTimestamps00:00 – Mathilda Martin joins Stewart Alsop to talk about art, creativity, and her upcoming exhibitions in Miami and Uruguay.05:00 – She shares how swimming connects to painting, describing water as calm, presence, and a source of flow and meditation.10:00 – They discuss art as therapy, childhood creativity, and overcoming fear by simply starting to create.15:00 – Mathilda reflects on her love for Van Gogh and feeling as the essence of authentic art, contrasting it with the coldness of AI.20:00 – The conversation turns to the value of human-made art and whether galleries can tell the difference between AI and real artists.25:00 – They explore Argentine authenticity, “chantas,” and what makes Argentina both chaotic and deeply real.30:00 – Mathilda talks about solidarity, community, and daily life in Buenos Aires amid political and economic instability.35:00 – She highlights Argentine muralists and how collaboration and scale transform artistic expression.40:00 – The pair discuss the commercialization of art, the “factory artist,” and staying true to feeling over fame.45:00 – Mathilda explains how COVID reshaped the art world, empowering independent artists to exhibit without galleries.50:00 – They end with art markets in Argentina vs. the U.S., her gallery in New York, and upcoming shows at Spectrum Miami and Punta del Este.Key InsightsArt and Water Share the Same Flow: Mathilda Martin reveals how swimming and painting both bring her into a meditative state she calls “the pause.” In the water, she feels the same stillness she experiences while painting — a total immersion in the present moment where the outside world disappears.Art Is a Form of Healing: Mathilda emphasizes that art is not just expression but medicine. She references the World Health Organization's recognition that creativity benefits mental and physical health, describing painting as a space of emotional regulation and clarity.Human-Made Art Has Soul, AI Doesn't: One of the episode's most thought-provoking moments comes when Mathilda contrasts the warmth of human-made art with the cold precision of AI. She believes that while AI can replicate technique, it can't replicate feeling — and that collectors will always value art infused with human emotion.Authenticity Defines Argentine Culture: Mathilda paints a vivid picture of Argentina as a land of contradictions — full of chaos, charm, and honesty. Argentines, she says, are “authentic, sometimes too direct,” a quality that shapes both their relationships and their art.COVID-19 Changed the Art World Forever: The pandemic disrupted the old gallery system and gave artists freedom to organize their own exhibitions. For Mathilda, this shift created independence, even if it also demanded new entrepreneurial skills.Commercial Success vs. Soulful Creation: Mathilda critiques “factory artists” who mass-produce work for fame or profit, contrasting them with artists who create from genuine emotion. The real challenge, she says, is maintaining authenticity in a system that rewards volume over vulnerability.Art as Connection and Presence: Beyond skill or aesthetics, Mathilda believes true art is about human connection — between artist, viewer, and the moment of creation itself. Whether painting, swimming, or teaching workshops, she views art as an ongoing conversation with life's deeper flow.

Thick toxic smog and air quality or AQI levels up to 35 times higher than the World Health Organization (WHO) limits are turning Delhi's winters into a recurring health emergency.Balakrishna Pisupati, head of the UN Environment Programme (UNEP) office in India, warns that pollution is “almost reaching the level of a disaster.”In an interview with UN News, he cites vehicle emissions, crop burning, industrial activity, construction dust and stagnant winter air as key contributors.Despite programmes and investments, progress can feel like “running on a treadmill” due to policy gaps, weak enforcement and little change in behaviour.UN News' Anshu Sharma spoke to Mr. Pisupati on how UNEP is addressing India's air pollution challenge, and the urgent need for coordinated action on fossil fuels and forest conservation.

Headaches are one of the most common neurological conditions in the world. They're also one of the most debilitating, mysterious, and misunderstood.According to the World Health Organization, 3 billion people worldwide suffer from headache disorders. And one in six Americans suffers from headaches that are so severe they limit their ability to work, sleep, or otherwise function.We discuss headaches as a part of our series “In Good Health,” where we talk about the bodily issues that most affect us. What do we know about headaches and who they affect? What works when it comes to treating headaches?Find more of our programs online. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a. Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Teenagers today are more "connected" than ever—and also more alone than ever. In this episode, I break down what researchers are calling a teenage loneliness epidemic and how it's quietly shaping our kids' emotional, social, and spiritual health. Large global studies show that about 1 in 9 adolescents worldwide report feeling lonely "most of the time" or "always." Long-term data also shows that by 2018, high loneliness levels in adolescents had nearly doubled compared to 2012. In the U.S., young people hold some of the highest loneliness rates of any age group, with one national report showing 61% of young adults experiencing "serious loneliness." We'll also get into the conversation around a "male loneliness epidemic." Some recent findings show men ages 15–34 report higher day-to-day loneliness than women the same age, even though overall, large-scale research suggests gender differences in loneliness are actually quite small. So what does that mean for your son—or your daughter? In this episode, I talk about: What's really driving the rise in teen loneliness (and why it's not as simple as "social media = bad"). How our parental habits—pace, expectations, emotional modeling—can unintentionally deepen the problem or help solve it. Practical, realistic ways to create connection with teens who seem withdrawn, prickly, or hard to reach. How boys and girls experience loneliness differently, and what each needs from the adults in their lives. How to offer yourself compassion as you learn new ways of showing up for your teen. This isn't about guilt. It's about naming what's real, supporting families with compassion, and giving you tools that bring connection back into the relationship. I'd love to chat with you about how this is playing out in your home. Book a free call HERE References 1. World Health Organization (WHO). (2021). Adolescent mental health: Global prevalence of loneliness in 13–17 year olds. https://www.who.int/publications 2. López Steinmetz, L. C., et al. (2021). Loneliness among adolescents across 37 countries: Trends from 2000–2018. Journal of Adolescent Health, 69(6), 993–1002. https://doi.org/10.1016/j.jadohealth.2021.08.009 3. Harvard Graduate School of Education: Making Caring Common Project. (2021). Loneliness in America: How the pandemic has deepened an epidemic of loneliness and what we can do about it. https://mcc.gse.harvard.edu 4. Cigna. (2020). U.S. Loneliness Index: Gen Z and young adults experience the highest loneliness levels. https://www.cigna.com 5. Gallup. (2023). Men report higher rates of daily loneliness than women in many age groups. https://news.gallup.com 6. Maes, M., Van den Noortgate, W., & Goossens, L. (2016). Gender differences in loneliness across the lifespan: A meta-analysis. European Journal of Personality, 30(1), 70–85. https://doi.org/10.1002/per.2034

We know the usual pillars of health; sleep, exercise, watch your diet and maintain social connections. Dr Daisy Fancourt says her research shows we need to add a fifth pillar, creativity. She's a professor of psychobiology and epidemiology at University College London and Director of the World Health Organization's Collaborating Center on Arts. Her research explores the powerful impact of engaging with art in any form, from music and dance to literature, cultural sites, and even street art. She shares what science says about the power of art

This week on The Broski Report, Fearless Leader Brittany Broski addresses some recent rumors, shares her Thanksgiving invite list, and researches gelatinous food. Watch The Broski Report AD FREE: https://patreon.com/broskireport  The OFFICIAL Songs of The Week Playlist: https://open.spotify.com/playlist/3ULrcEqO2JafGZPeonyuje?si=061c5c0dd4664f01 

In a moment marked by rising geopolitical instability, accelerating climate change, recurring pandemics, and deep economic uncertainty, nursing stands at a critical crossroads. The global nursing workforce is already under severe strain, and the World Health Organization projects a shortfall of approximately 4.5 million nurses by 2030. Yet, even as health needs become more complex, health funding is being reduced in many parts of the world while defense spending rises, deepening the resource constraints facing nurses and other frontline health workers.  So, what does it truly mean to invest in nursing?  For the International Council of Nurses, it means speaking value to power, making the case consistently and convincingly, that nurses are essential to the stability and well-being of individuals, families, communities, and entire nations. It means pushing forward despite workforce shortages, policy barriers, violence, and chronic underfunding. It means dismantling myths and hierarchies and advancing rigorous research to demonstrate the economic and societal return on educating, compensating, and recognizing nurses as the indispensable professionals they are.  In this episode, Oriana Beaudet, VP of Innovation at the American Nurses Association, Credentialing Center, and Foundation, connects with Howard Catton, the Chief Executive Officer of the International Council of Nurses, who is driving global efforts to support nurses at the ICN. Together, they explore the inventive strategies, advocacy work, and bold solutions shaping the future of nursing. And talk about what it means to meet global challenges with clarity, commitment, and heart. 

About the Guest(s): Dr. Kristin Hieshetter is the host of the "Functional Health Radio" podcast. Dr. Kristen is an expert in holistic health practices and functional medicine, bringing years of experience in treating patients with a focus on integrative approaches. Her keen interest lies in enabling individuals to reach optimal health through informed decisions and lifestyle changes. Dr. Kristen is known for her engaging discussions on contemporary health topics, as well as her dedication to improving public health awareness internationally. Episode Summary: In this episode of "Functional Health Radio," Dr. Kristin Hieshetter delves into the intriguing topic of Ivermectin, exploring its potential use beyond its historical application as an anti-parasitic medication. Spurred by questions from her patients, Dr. Kristen investigates whether Ivermectin could be effectively repurposed for cancer treatment, a subject gaining them significant attention and research interest in recent years. She discusses how Ivermectin has a history of effectiveness in treating parasitic infections, but also reveals new and promising research that suggests its potential role in oncology. The episode highlights Dr. Kristen's detailed exploration of scientific studies on Ivermectin's effect on various cancer types, including bladder cancer, esophageal cancer, pancreatic cancer, and triple-negative breast cancer. Dr. Kristen refers to multiple research articles and findings, emphasizing Ivermectin's mechanism of action, which includes inducing oxidative stress and DNA damage in cancer cells. Throughout the discussion, she provides a compelling narrative about the potential paradigm shifts in cancer treatment and urges listeners to consider these findings, especially if they or their loved ones are affected by these conditions. Key Takeaways: Ivermectin, originally discovered as an anti-parasitic drug, is being researched for its potential use in cancer treatment, thanks to its ability to induce cancer cell death. Recent studies have shown that Ivermectin may enhance the efficacy of existing chemotherapy treatments, particularly for difficult-to-treat cancers like pancreatic and triple-negative breast cancer. Ivermectin has demonstrated the ability to selectively target and cause apoptosis in cancer cells without harming normal cells. While historical usage of Ivermectin in human treatments is well-established, ongoing research into its applications in oncology could mark a significant shift in therapeutic strategies. Despite its promising potential, listeners are cautioned about the importance of consulting medical professionals before considering any new treatments. Notable Quotes: "Ivermectin is much more than a horse dewormer; it's cheap, effective, and has been widely used for human treatment since 1987." "This study primarily looked at ivermectin, and it wasn't a combination therapy. It was just ivermectin, showing very good results against bladder cancer." "Pancreatic cancer is characterized by a really high death rate and very poor prognosis, making ivermectin's potential effects particularly exciting." "You've got this modulated electrohyperthermia, you can exploit the difference in the electromagnetic field and bioelectrical properties between cancer cells and regular tissues." "Ivermectin exerts anti-cancer effects by activating the same pathways it targets in parasites, which is an extraordinary finding." Resources: PubMed: A source of numerous articles Dr. Kristin referenced in her research on Ivermectin and its potential in cancer treatment PubMed. World Health Organization's List of Essential Medicines: Inclusion of Ivermectin as an essential anti-parasitic treatment. YouTube Channel: Dr. Kristin may reference visual media for additional context on various topics discussed in the podcast. Dr. Kristin Hieshetter shares her insights and encourages listeners to explore these discussions further with their healthcare providers. Don't miss the opportunity to hear the complete episode for an in-depth understanding of Ivermectin's potential impact on cancer therapy and more enriching health content each week on "Functional Health Radio." Stay tuned for progressive updates and responsible health discussions led by Dr. Kristin.

Global Health Matters is the monthly podcast from TDR, please subscribe.  GHMs brings you topical subjects and insightful discussions with health experts from across the globe, including a focus on low-to middle-income countries. Are you a professional looking to progress further or perhaps a global health student at the early stage of your career? There are so many routes to get into a career in global health, so this podcast episode discussion is with two career professionals sharing their knowledge of how they chose their path and giving clear guidance on ways to get the support needed to increase opportunities to make a difference in the ever pressing global health challenges.  Global Health Matters host Garry Aslanyan speaks with the following guests: Stephanie Topp: Associate Professor, Global Health and Development, College of Public Health, James Cook UniversityRenzo Guinto: Chief Planetary Health Scientist, Sunway Centre for Planetary Health and Director, Planetary and Global Health, St. Luke's Medical Center Stephanie Topp looks at how global health can support the next generation of thinkers and leaders, and suggests that networked capacity building and an emerging voices model is a critical example. Renzo Guinto wants to listen to different voices and challenge power structures to address the inequities that global health is trying to address.Related episode documents, transcripts and other information can be found on our website.Subscribe to the Global Health Matters podcast newsletter.  Follow us for updates:@TDRnews on XTDR on LinkedIn@ghm_podcast on Instagram@ghm-podcast.bsky.social on Bluesky Disclaimer: The views, information, or opinions expressed during the Global Health Matters podcast series are solely those of the individuals involved and do not necessarily represent those of TDR or the World Health Organization.  All content © 2025 Global Health Matters.

Send us a textCOP30 has ended without a firm commitment to phase out fossil fuels. Inside Geneva talks to some campaigners who remain surprisingly optimistic.“I'm actually quite hopeful, and I think that the answer is probably coming from the countries and the communities that have the most to lose,” says Candy Ofime, from the Climate Justice Team at Amnesty International.Indigenous peoples made their voices heard at COP30.They have deep knowledge of land use and forest preservation, which can help us tackle global warming.“The answer is us and that was part of the campaign that we had as indigenous peoples. [We said] ‘pay attention to the world.' Basically the solution that many of us are looking for has already been happening in the indigenous local communities,” says Deborah Sanchez, from the Community Land Rights and Climate Initiative (Clarifi).  Some now suggest global warming is a hoax…but the scientific evidence proves otherwise. It is damaging our planet and our health.“These are clever people who want what's best for you and can read a temperature graph, and they know that there are concrete actions that you can take which are good for your health, as well as good for the planet,” says Diarmid Campbell Lendrum, from the climate change and health unit at the World Health Organization (WHO). So does it matter that the world's super power, and biggest emitter of greenhouse gases, stayed away from COP30?“The US is usually a blocker, and sometimes having the biggest polluters not in the room allows for consensus to be reached. And so in this forum, decisions have to be made, and they will be made with or without the United States,” says Ofime. Can the world tackle climate change without the US? Join host Imogen Foulkes on Inside Geneva. Get in touch! Email us at insidegeneva@swissinfo.ch Twitter: @ImogenFoulkes and @swissinfo_en Thank you for listening! If you like what we do, please leave a review or subscribe to our newsletter. For more stories on the international Geneva please visit www.swissinfo.ch/Host: Imogen FoulkesProduction assitant: Claire-Marie GermainDistribution: Sara PasinoMarketing: Xin Zhang

How can you write science-based fiction without info-dumping your research? How can you use AI tools in a creative way, while still focusing on a human-first approach? Why is adapting to the fast pace of change so difficult and how can we make the most of this time? Jamie Metzl talks about Superconvergence and more. In the intro, How to avoid author scams [Written Word Media]; Spotify vs Audible audiobook strategy [The New Publishing Standard]; Thoughts on Author Nation and why constraints are important in your author life [Self-Publishing with ALLi]; Alchemical History And Beautiful Architecture: Prague with Lisa M Lilly on my Books and Travel Podcast. Today's show is sponsored by Draft2Digital, self-publishing with support, where you can get free formatting, free distribution to multiple stores, and a host of other benefits. Just go to www.draft2digital.com to get started. This show is also supported by my Patrons. Join my Community at Patreon.com/thecreativepenn Jamie Metzl is a technology futurist, professional speaker, entrepreneur, and the author of sci-fi thrillers and futurist nonfiction books, including the revised and updated edition of Superconvergence: How the Genetics, Biotech, and AI Revolutions Will Transform Our Lives, Work, and World. You can listen above or on your favorite podcast app or read the notes and links below. Here are the highlights and the full transcript is below. Show Notes How personal history shaped Jamie's fiction writing Writing science-based fiction without info-dumping The super convergence of three revolutions (genetics, biotech, AI) and why we need to understand them holistically Using fiction to explore the human side of genetic engineering, life extension, and robotics Collaborating with GPT-5 as a named co-author How to be a first-rate human rather than a second-rate machine You can find Jamie at JamieMetzl.com. Transcript of interview with Jamie Metzl Jo: Jamie Metzl is a technology futurist, professional speaker, entrepreneur, and the author of sci-fi thrillers and futurist nonfiction books, including the revised and updated edition of Superconvergence: How the Genetics, Biotech, and AI Revolutions Will Transform Our Lives, Work, and World. So welcome, Jamie. Jamie: Thank you so much, Jo. Very happy to be here with you. Jo: There is so much we could talk about, but let's start with you telling us a bit more about you and how you got into writing. From History PhD to First Novel Jamie: Well, I think like a lot of writers, I didn't know I was a writer. I was just a kid who loved writing. Actually, just last week I was going through a bunch of boxes from my parents' house and I found my autobiography, which I wrote when I was nine years old. So I've been writing my whole life and loving it. It was always something that was very important to me. When I finished my DPhil, my PhD at Oxford, and my dissertation came out, it just got scooped up by Macmillan in like two minutes. And I thought, “God, that was easy.” That got me started thinking about writing books. I wanted to write a novel based on the same historical period – my PhD was in Southeast Asian history – and I wanted to write a historical novel set in the same period as my dissertation, because I felt like the dissertation had missed the human element of the story I was telling, which was related to the Cambodian genocide and its aftermath. So I wrote what became my first novel, and I thought, “Wow, now I'm a writer.” I thought, “All right, I've already published one book. I'm gonna get this other book out into the world.” And then I ran into the brick wall of: it's really hard to be a writer. It's almost easier to write something than to get it published. I had to learn a ton, and it took nine years from when I started writing that first novel, The Depths of the Sea, to when it finally came out. But it was such a positive experience, especially to have something so personal to me as that story. I'd lived in Cambodia for two years, I'd worked on the Thai-Cambodian border, and I'm the child of a Holocaust survivor. So there was a whole lot that was very emotional for me. That set a pattern for the rest of my life as a writer, at least where, in my nonfiction books, I'm thinking about whatever the issues are that are most important to me. Whether it was that historical book, which was my first book, or Hacking Darwin on the future of human genetic engineering, which was my last book, or Superconvergence, which, as you mentioned in the intro, is my current book. But in every one of those stories, the human element is so deep and so profound. You can get at some of that in nonfiction, but I've also loved exploring those issues in deeper ways in my fiction. So in my more recent novels, Genesis Code and Eternal Sonata, I've looked at the human side of the story of genetic engineering and human life extension. And now my agent has just submitted my new novel, Virtuoso, about the intersection of AI, robotics, and classical music. With all of this, who knows what's the real difference between fiction and nonfiction? We're all humans trying to figure things out on many different levels. Shifting from History to Future Tech Jo: I knew that you were a polymath, someone who's interested in so many things, but the music angle with robotics and AI is fascinating. I do just want to ask you, because I was also at Oxford – what college were you at? Jamie: I was in St. Antony's. Jo: I was at Mansfield, so we were in that slightly smaller, less famous college group, if people don't know. Jamie: You know, but we're small but proud. Jo: Exactly. That's fantastic. You mentioned that you were on the historical side of things at the beginning and now you've moved into technology and also science, because this book Superconvergence has a lot of science. So how did you go from history and the past into science and the future? Biology and Seeing the Future Coming Jamie: It's a great question. I'll start at the end and then back up. A few years ago I was speaking at Lawrence Livermore National Laboratory, which is one of the big scientific labs here in the United States. I was a guest of the director and I was speaking to their 300 top scientists. I said to them, “I'm here to speak with you about the future of biology at the invitation of your director, and I'm really excited. But if you hear something wrong, please raise your hand and let me know, because I'm entirely self-taught. The last biology course I took was in 11th grade of high school in Kansas City.” Of course I wouldn't say that if I didn't have a lot of confidence in my process. But in many ways I'm self-taught in the sciences. As you know, Jo, and as all of your listeners know, the foundation of everything is curiosity and then a disciplined process for learning. Even our greatest super-specialists in the world now – whatever their background – the world is changing so fast that if anyone says, “Oh, I have a PhD in physics/chemistry/biology from 30 years ago,” the exact topic they learned 30 years ago is less significant than their process for continuous learning. More specifically, in the 1990s I was working on the National Security Council for President Clinton, which is the president's foreign policy staff. My then boss and now close friend, Richard Clarke – who became famous as the guy who had tragically predicted 9/11 – used to say that the key to efficacy in Washington and in life is to try to solve problems that other people can't see. For me, almost 30 years ago, I felt to my bones that this intersection of what we now call AI and the nascent genetics revolution and the nascent biotechnology revolution was going to have profound implications for humanity. So I just started obsessively educating myself. When I was ready, I started writing obscure national security articles. Those got a decent amount of attention, so I was invited to testify before the United States Congress. I was speaking out a lot, saying, “Hey, this is a really important story. A lot of people are missing it. Here are the things we should be thinking about for the future.” I wasn't getting the kind of traction that I wanted. I mentioned before that my first book had been this dry Oxford PhD dissertation, and that had led to my first novel. So I thought, why don't I try the same approach again – writing novels to tell this story about the genetics, biotech, and what later became known popularly as the AI revolution? That led to my two near-term sci-fi novels, Genesis Code and Eternal Sonata. On my book tours for those novels, when I explained the underlying science to people in my way, as someone who taught myself, I could see in their eyes that they were recognizing not just that something big was happening, but that they could understand it and feel like they were part of that story. That's what led me to write Hacking Darwin, as I mentioned. That book really unlocked a lot of things. I had essentially predicted the CRISPR babies that were born in China before it happened – down to the specific gene I thought would be targeted, which in fact was the case. After that book was published, Dr. Tedros, the Director-General of the World Health Organization, invited me to join the WHO Expert Advisory Committee on Human Genome Editing, which I did. It was a really great experience and got me thinking a lot about the upside of this revolution and the downside. The Birth of Superconvergence Jamie: I get a lot of wonderful invitations to speak, and I have two basic rules for speaking: Never use notes. Never ever. Never stand behind a podium. Never ever. Because of that, when I speak, my talks tend to migrate. I'd be speaking with people about the genetics revolution as it applied to humans, and I'd say, “Well, this is just a little piece of a much bigger story.” The bigger story is that after nearly four billion years of life on Earth, our one species has the increasing ability to engineer novel intelligence and re-engineer life. The big question for us, and frankly for the world, is whether we're going to be able to use that almost godlike superpower wisely. As that idea got bigger and bigger, it became this inevitable force. You write so many books, Jo, that I think it's second nature for you. Every time I finish a book, I think, “Wow, that was really hard. I'm never doing that again.” And then the books creep up on you. They call to you. At some point you say, “All right, now I'm going to do it.” So that was my current book, Superconvergence. Like everything, every journey you take a step, and that step inspires another step and another. That's why writing and living creatively is such a wonderfully exciting thing – there's always more to learn and always great opportunities to push ourselves in new ways. Balancing Deep Research with Good Storytelling Jo: Yeah, absolutely. I love that you've followed your curiosity and then done this disciplined process for learning. I completely understand that. But one of the big issues with people like us who love the research – and having read your Superconvergence, I know how deeply you go into this and how deeply you care that it's correct – is that with fiction, one of the big problems with too much research is the danger of brain-dumping. Readers go to fiction for escapism. They want the interesting side of it, but they want a story first. What are your tips for authors who might feel like, “Where's the line between putting in my research so that it's interesting for readers, but not going too far and turning it into a textbook?” How do you find that balance? Jamie: It's such a great question. I live in New York now, but I used to live in Washington when I was working for the U.S. government, and there were a number of people I served with who later wrote novels. Some of those novels felt like policy memos with a few sex scenes – and that's not what to do. To write something that's informed by science or really by anything, everything needs to be subservient to the story and the characters. The question is: what is the essential piece of information that can convey something that's both important to your story and your character development, and is also an accurate representation of the world as you want it to be? I certainly write novels that are set in the future – although some of them were a future that's now already happened because I wrote them a long time ago. You can make stuff up, but as an author you have to decide what your connection to existing science and existing technology and the existing world is going to be. I come at it from two angles. One: I read a huge number of scientific papers and think, “What does this mean for now, and if you extrapolate into the future, where might that go?” Two: I think about how to condense things. We've all read books where you're humming along because people read fiction for story and emotional connection, and then you hit a bit like: “I sat down in front of the president, and the president said, ‘Tell me what I need to know about the nuclear threat.'” And then it's like: insert memo. That's a deal-killer. It's like all things – how do you have a meaningful relationship with another person? It's not by just telling them your story. Even when you're telling them something about you, you need to be imagining yourself sitting in their shoes, hearing you. These are very different disciplines, fiction and nonfiction. But for the speculative nonfiction I write – “here's where things are now, and here's where the world is heading” – there's a lot of imagination that goes into that too. It feels in many ways like we're living in a sci-fi world because the rate of technological change has been accelerating continuously, certainly for the last 12,000 years since the dawn of agriculture. It's a balance. For me, I feel like I'm a better fiction writer because I write nonfiction, and I'm a better nonfiction writer because I write fiction. When I'm writing nonfiction, I don't want it to be boring either – I want people to feel like there's a story and characters and that they can feel themselves inside that story. Jo: Yeah, definitely. I think having some distance helps as well. If you're really deep into your topics, as you are, you have to leave that manuscript a little bit so you can go back with the eyes of the reader as opposed to your eyes as the expert. Then you can get their experience, which is great. Looking Beyond Author-Focused AI Fears Jo: I want to come to your technical knowledge, because AI is a big thing in the author and creative community, like everywhere else. One of the issues is that creators are focusing on just this tiny part of the impact of AI, and there's a much bigger picture. For example, in 2024, Demis Hassabis from Google DeepMind and his collaborative partner John Jumper won the Nobel Prize for Chemistry with AlphaFold. It feels to me like there's this massive world of what's happening with AI in health, climate, and other areas, and yet we are so focused on a lot of the negative stuff. Maybe you could give us a couple of things about what there is to be excited and optimistic about in terms of AI-powered science? Jamie: Sure. I'm so excited about all of the new opportunities that AI creates. But I also think there's a reason why evolution has preserved this very human feeling of anxiety: because there are real dangers. Anybody who's Pollyanna-ish and says, “Oh, the AI story is inevitably positive,” I'd be distrustful. And anyone who says, “We're absolutely doomed, this is the end of humanity,” I'd also be distrustful. So let me tell you the positives and the negatives, and maybe some thoughts about how we navigate toward the former and away from the latter. AI as the New Electricity Jamie: When people think of AI right now, they're thinking very narrowly about these AI tools and ChatGPT. But we don't think of electricity that way. Nobody says, “I know electricity – electricity is what happens at the power station.” We've internalised the idea that electricity is woven into not just our communication systems or our houses, but into our clothes, our glasses – it's woven into everything and has super-empowered almost everything in our modern lives. That's what AI is. In Superconvergence, the majority of the book is about positive opportunities: In healthcare, moving from generalised healthcare based on population averages to personalised or precision healthcare based on a molecular understanding of each person's individual biology. As we build these massive datasets like the UK Biobank, we can take a next jump toward predictive and preventive healthcare, where we're able to address health issues far earlier in the process, when interventions can be far more benign. I'm really excited about that, not to mention the incredible new kinds of treatments – gene therapies, or pharmaceuticals based on genetics and systems-biology analyses of patients. Then there's agriculture. Over the last hundred years, because of the technologies of the Green Revolution and synthetic fertilisers, we've had an incredible increase in agricultural productivity. That's what's allowed us to quadruple the global population. But if we just continue agriculture as it is, as we get towards ten billion wealthier, more empowered people wanting to eat like we eat, we're going to have to wipe out all the wild spaces on Earth to feed them. These technologies help provide different paths toward increasing agricultural productivity with fewer inputs of land, water, fertiliser, insecticides, and pesticides. That's really positive. I could go on and on about these positives – and I do – but there are very real negatives. I was a member of the WHO Expert Advisory Committee on Human Genome Editing after the first CRISPR babies were very unethically created in China. I'm extremely aware that these same capabilities have potentially incredible upsides and very real downsides. That's the same as every technology in the past, but this is happening so quickly that it's triggering a lot of anxieties. Governance, Responsibility, and Why Everyone Has a Role Jamie: The question now is: how do we optimise the benefits and minimise the harms? The short, unsexy word for that is governance. Governance is not just what governments do; it's what all of us do. That's why I try to write books, both fiction and nonfiction, to bring people into this story. If people “other” this story – if they say, “There's a technology revolution, it has nothing to do with me, I'm going to keep my head down” – I think that's dangerous. The way we're going to handle this as responsibly as possible is if everybody says, “I have some role. Maybe it's small, maybe it's big. The first step is I need to educate myself. Then I need to have conversations with people around me. I need to express my desires, wishes, and thoughts – with political leaders, organisations I'm part of, businesses.” That has to happen at every level. You're in the UK – you know the anti-slavery movement started with a handful of people in Cambridge and grew into a global movement. I really believe in the power of ideas, but ideas don't spread on their own. These are very human networks, and that's why writing, speaking, communicating – probably for every single person listening to this podcast – is so important. Jo: Mm, yeah. Fiction Like AI 2041 and Thinking Through the Issues Jo: Have you read AI 2041 by Kai-Fu Lee and Chen Qiufan? Jamie: No. I heard a bunch of their interviews when the book came out, but I haven't read it. Jo: I think that's another good one because it's fiction – a whole load of short stories. It came out a few years ago now, but the issues they cover in the stories, about different people in different countries – I remember one about deepfakes – make you think more about the topics and help you figure out where you stand. I think that's the issue right now: it's so complex, there are so many things. I'm generally positive about AI, but of course I don't want autonomous drone weapons, you know? The Messy Reality of “Bad” Technologies Jamie: Can I ask you about that? Because this is why it's so complicated. Like you, I think nobody wants autonomous killer drones anywhere in the world. But if you right now were the defence minister of Ukraine, and your children are being kidnapped, your country is being destroyed, you're fighting for your survival, you're getting attacked every night – and you're getting attacked by the Russians, who are investing more and more in autonomous killer robots – you kind of have two choices. You can say, “I'm going to surrender,” or, “I'm going to use what technology I have available to defend myself, and hopefully fight to either victory or some kind of stand-off.” That's what our societies did with nuclear weapons. Maybe not every American recognises that Churchill gave Britain's nuclear secrets to America as a way of greasing the wheels of the Anglo-American alliance during the Second World War – but that was our programme: we couldn't afford to lose that war, and we couldn't afford to let the Nazis get nuclear weapons before we did. So there's the abstract feeling of, “I'm against all war in the abstract. I'm against autonomous killer robots in the abstract.” But if I were the defence minister of Ukraine, I would say, “What will it take for us to build the weapons we can use to defend ourselves?” That's why all this stuff gets so complicated. And frankly, it's why the relationship between fiction and nonfiction is so important. If every novel had a situation where every character said, “Oh, I know exactly the right answer,” and then they just did the right answer and it was obviously right, it wouldn't make for great fiction. We're dealing with really complex humans. We have conflicting impulses. We're not perfect. Maybe there are no perfect answers – but how do we strive toward better rather than worse? That's the question. Jo: Absolutely. I don't want to get too political on things. How AI Is Changing the Writing Life Jo: Let's come back to authors. In terms of the creative process, the writing process, the research process, and the business of being an author – what are some of the ways that you already use AI tools, and some of the ways, given your futurist brain, that you think things are going to change for us? Jamie: Great question. I'll start with a little middle piece. I found you, Jo, through GPT-5. I asked ChatGPT, “I'm coming out with this book and I want to connect with podcasters who are a little different from the ones I've done in the past. I've been a guest on Joe Rogan twice and some of the bigger podcasts. Make me a list of really interesting people I can have great conversations with.” That's how I found you. So this is one reward of that process. Let me say that in the last year I've worked on three books, and I'll explain how my relationship with AI has changed over those books. Cleaning Up Citations (and Getting Burned) Jamie: First is the highly revised paperback edition of Superconvergence. When the hardback came out, I had – I don't normally work with research assistants because I like to dig into everything myself – but the one thing I do use a research assistant for is that I can't be bothered, when I'm writing something, to do the full Chicago-style footnote if I'm already referencing an academic paper. So I'd just put the URL as the footnote and then hire a research assistant and say, “Go to this URL and change it into a Chicago-style citation. That's it.” Unfortunately, my research assistant on the hardback used early-days ChatGPT for that work. He did the whole thing, came back, everything looked perfect. I said, “Wow, amazing job.” It was only later, as I was going through them, that I realised something like 50% of them were invented footnotes. It was very painful to go back and fix, and it took ten times more time. With the paperback edition, I didn't use AI that much, but I did say things like, “Here's all the information – generate a Chicago-style citation.” That was better. I noticed there were a few things where I stopped using the thesaurus function on Microsoft Word because I'd just put the whole paragraph into the AI and say, “Give me ten other options for this one word,” and it would be like a contextual thesaurus. That was pretty good. Talking to a Robot Pianist Character Jamie: Then, for my new novel Virtuoso, I was writing a character who is a futurist robot that plays the piano very beautifully – not just humanly, but almost finding new things in the music we've written and composing music that resonates with us. I described the actions of that robot in the novel, but I didn't describe the inner workings of the robot's mind. In thinking about that character, I realised I was the first science-fiction writer in history who could interrogate a machine about what it was “thinking” in a particular context. I had the most beautiful conversations with ChatGPT, where I would give scenarios and ask, “What are you thinking? What are you feeling in this context?” It was all background for that character, but it was truly profound. Co-Authoring The AI Ten Commandments with GPT-5 Jamie: Third, I have another book coming out in May in the United States. I gave a talk this summer at the Chautauqua Institution in upstate New York about AI and spirituality. I talked about the history of our human relationship with our technology, about how all our religious and spiritual traditions have deep technological underpinnings – certainly our Abrahamic religions are deeply connected to farming, and Protestantism to the printing press. Then I had a section about the role of AI in generating moral codes that would resonate with humans. Everybody went nuts for this talk, and I thought, “I think I'm going to write a book.” I decided to write it differently, with GPT-5 as my named co-author. The first thing I did was outline the entire book based on the talk, which I'd already spent a huge amount of time thinking about and organising. Then I did a full outline of the arguments and structures. Then I trained GPT-5 on my writing style. The way I did it – which I fully describe in the introduction to the book – was that I'd handle all the framing: the full introduction, the argument, the structure. But if there was a section where, for a few paragraphs, I was summarising a huge field of data, even something I knew well, I'd give GPT-5 the intro sentence and say, “In my writing style, prepare four paragraphs on this.” For example, I might write: “AI has the potential to see us humans like we humans see ant colonies.” Then I'd say, “Give me four paragraphs on the relationship between the individual and the collective in ant colonies.” I could have written those four paragraphs myself, but it would've taken a month to read the life's work of E.O. Wilson and then write them. GPT-5 wrote them in seconds or minutes, in its thinking mode. I'd then say, “It's not quite right – change this, change that,” and we'd go back and forth three or four times. Then I'd edit the whole thing and put it into the text. So this book that I could have written on my own in a year, I wrote a first draft of with GPT-5 as my named co-author in two days. The whole project will take about six months from start to finish, and I'm having massive human editing – multiple edits from me, plus a professional editor. It's not a magic AI button. But I feel strongly about listing GPT-5 as a co-author because I've written it differently than previous books. I'm a huge believer in the old-fashioned lone author struggling and suffering – that's in my novels, and in Virtuoso I explore that. But other forms are going to emerge, just like video games are a creative, artistic form deeply connected to technology. The novel hasn't been around forever – the current format is only a few centuries old – and forms are always changing. There are real opportunities for authors, and there will be so much crap flooding the market because everybody can write something and put it up on Amazon. But I think there will be a very special place for thoughtful human authors who have an idea of what humans do at our best, and who translate that into content other humans can enjoy. Traditional vs Indie: Why This Book Will Be Self-Published Jo: I'm interested – you mentioned that it's your named co-author. Is this book going through a traditional publisher, and what do they think about that? Or are you going to publish it yourself? Jamie: It's such a smart question. What I found quickly is that when you get to be an author later in your career, you have all the infrastructure – a track record, a fantastic agent, all of that. But there were two things that were really important to me here: I wanted to get this book out really fast – six months instead of a year and a half. It was essential to me to have GPT-5 listed as my co-author, because if it were just my name, I feel like it would be dishonest. Readers who are used to reading my books – I didn't want to present something different than what it was. I spoke with my agent, who I absolutely love, and she said that for this particular project it was going to be really hard in traditional publishing. So I did a huge amount of research, because I'd never done anything in the self-publishing world before. I looked at different models. There was one hybrid model that's basically the same as traditional, but you pay for the things the publisher would normally pay for. I ended up not doing that. Instead, I decided on a self-publishing route where I disaggregated the publishing process. I found three teams: one for producing the book, one for getting the book out into the world, and a smaller one for the audiobook. I still believe in traditional publishing – there's a lot of wonderful human value-add. But some works just don't lend themselves to traditional publishing. For this book, which is called The AI Ten Commandments, that's the path I've chosen. Jo: And when's that out? I think people will be interested. Jamie: April 26th. Those of us used to traditional publishing think, “I've finished the book, sold the proposal, it'll be out any day now,” and then it can be a year and a half. It's frustrating. With this, the process can be much faster because it's possible to control more of the variables. But the key – as I was saying – is to make sure it's as good a book as everything else you've written. It's great to speed up, but you don't want to compromise on quality. The Coming Flood of Excellent AI-Generated Work Jo: Yeah, absolutely. We're almost out of time, but I want to come back to your “flood of crap” and the “AI slop” idea that's going around. Because you are working with GPT-5 – and I do as well, and I work with Claude and Gemini – and right now there are still issues. Like you said about referencing, there are still hallucinations, though fewer. But fast-forward two, five years: it's not a flood of crap. It's a flood of excellent. It's a flood of stuff that's better than us. Jamie: We're humans. It's better than us in certain ways. If you have farm machinery, it's better than us at certain aspects of farming. I'm a true humanist. I think there will be lots of things machines do better than us, but there will be tons of things we do better than them. There's a reason humans still care about chess, even though machines can beat humans at chess. Some people are saying things I fully disagree with, like this concept of AGI – artificial general intelligence – where machines do everything better than humans. I've summarised my position in seven letters: “AGI is BS.” The only way you can believe in AGI in that sense is if your concept of what a human is and what a human mind is is so narrow that you think it's just a narrow range of analytical skills. We are so much more than that. Humans represent almost four billion years of embodied evolution. There's so much about ourselves that we don't know. As incredible as these machines are and will become, there will always be wonderful things humans can do that are different from machines. What I always tell people is: whatever you're doing, don't be a second-rate machine. Be a first-rate human. If you're doing something and a machine is doing that thing much better than you, then shift to something where your unique capacities as a human give you the opportunity to do something better. So yes, I totally agree that the quality of AI-generated stuff will get better. But I think the most creative and successful humans will be the ones who say, “I recognise that this is creating new opportunities, and I'm going to insert my core humanity to do something magical and new.” People are “othering” these technologies, but the technologies themselves are magnificent human-generated artefacts. They're not alien UFOs that landed here. It's a scary moment for creatives, no doubt, because there are things all of us did in the past that machines can now do really well. But this is the moment where the most creative people ask themselves, “What does it mean for me to be a great human?” The pat answers won't apply. In my Virtuoso novel I explore that a lot. The idea that “machines don't do creativity” – they will do incredible creativity; it just won't be exactly human creativity. We will be potentially huge beneficiaries of these capabilities, but we really have to believe in and invest in the magic of our core humanity. Where to Find Jamie and His Books Jo: Brilliant. So where can people find you and your books online? Jamie: Thank you so much for asking. My website is jamiemetzl.com – and my books are available everywhere. Jo: Fantastic. Thanks so much for your time, Jamie. That was great. Jamie: Thank you, Joanna.The post Writing The Future, And Being More Human In An Age of AI With Jamie Metzl first appeared on The Creative Penn.

Episode 378 revisits Dr. Shane Creado's science-driven advice on sleep, strategic napping, and why sleep is foundational for health, hormones, immunity, and performance. Learn practical nap protocols (10–20 minutes or 90-minute recovery naps), timing, environment tips, and how to protect your morning from cortisol-spiking habits like checking phones. The episode also shows how combining a short nap with the Silva Method — setting an intention and entering alpha — can boost creativity, insight, and problem-solving. It concludes with actionable routines to improve sleep consistency, support shift workers, and make sleep a strategy for better productivity and well-being. Welcome back to SEASON 14 of The Neuroscience Meets Social and Emotional Learning Podcast, where we connect the science-based evidence behind social and emotional learning and emotional intelligence training for improved well-being, achievement, productivity and results—using what I saw as the missing link (since we weren't taught this when we were growing up in school), the application of practical neuroscience. I'm Andrea Samadi, and seven years ago, launched this podcast with a question I had never truly asked myself before: (and that is) If productivity and results matter to us—and they do now more than ever—how exactly are we using our brain to make them happen? Most of us were never taught how to apply neuroscience to improve productivity, results, or well-being. About a decade ago, I became fascinated by the mind-brain-results connection—and how science can be applied to our everyday lives. That's why I've made it my mission to bring you the world's top experts—so together, we can explore the intersection of science and social-emotional learning. We'll break down complex ideas and turn them into practical strategies we can use every day for predictable, science-backed results. This week, in our review of EP 72 with Shane Creado, MD and his book Peak Sleep Performance for Athletes and will learn:  How strategic napping, morning brain habits, and even the Silva Method all work together to reset your brain, boost performance, and transform your health from the inside out. Clip 1: The Science of Strategic Napping In Clip 1, Dr. Shane Creado explains why every cell in the body follows its own circadian rhythm—and why humans were historically wired for polymodal sleep, with natural dips in alertness that make afternoon naps biologically appropriate. You'll learn: Why the “post-lunch crash” is actually a melatonin rise, not just fatigue Why old advice to “avoid naps” is outdated How short, intentional naps can boost alertness, learning, mood, and performance The simple rules behind strategic napping: length, timing, and environment This clip lays the groundwork for using naps as a tool—not a crutch—for better brain function. Clip 2: Your Morning Cortisol Curve & Hidden Sleep Dangers Clip 2 shifts the focus to the first moments of your day. Dr. Creado warns that checking your phone the moment you wake up spikes cortisol and sends your brain into danger mode, increasing anxiety and disrupting emotional regulation for the entire day. You'll also learn: Why shift work fragments DNA Why the WHO classifies shift work as a possible carcinogen How sleep protects your hormones, immune system, gut health, and long-term aging This clip reinforces that sleep is foundational biology, not optional or replaceable. How This All Connects to The Silva Method We close the episode by tying these insights back to our most-listened-to series—the Silva Method. Both Dr. Creado's strategies and Silva's techniques point to the same powerful truth: When we intentionally shift the brain into restorative states—through sleep, strategic napping, or Alpha/Theta training—we unlock higher performance, creativity, intuition, and emotional stability. You'll see how: Strategic naps naturally guide the brain into Alpha and Theta brainwave patterns Morning routines that protect your cortisol curve mimic Silva's “mental housecleaning” Sleep resets the brain in the same way Silva exercises reset focus, clarity, and intuition Both methods teach us to work with the brain, not against it Together, the science of sleep and the mental training of Silva give you a complete framework for building peak performance from the inside out. Episode 378: Featuring Dr. Shane Creado (Integrating the Silva Method[i] for Increased Creativity-Nap Integration) For today's Episode 378, we continue with our review of past episodes as we make connections to prior learning with whatever it is that we are currently working on this year. I'll create a roadmap at the end of this season so this pathway will make sense to us (I hope!) as we piece together important parts of our success puzzle and begin to bring them to life. As we review these episodes, you'll notice that around the time of the pandemic, around 2020, our interviews took a turn towards health and wellness, and to stay on track, I created a framework of our Top 5 Health Staples on Episode 87[ii], which eventually evolved into our Top 6 Health Staples when we added stress reduction to help us to boost our physical and mental health. This week, we're going back to one of my favorite interviews with the inspiring Dr. Shane Creado, who we first met on EP 72[iii] in July 2020 on the topic of “Sleep Strategies that Will Guarantee a Competitive Advantage.” Dr. Creado is a double board-certified sleep medicine doctor and psychiatrist who practices functional sleep medicine, integrative psychiatry, and sports psychiatry. He brings all of these specialties together to uncover the underlying factors that sabotage our sleep and then treats them comprehensively, helping people to achieve their health and performance goals with sleep at the forefront. To quickly review his background: Dr. Creado completed an undergraduate degree in physical therapy, went on to earn his MD, and then completed a fellowship in Sleep Medicine at the University of Wisconsin, recognizing the huge overlap between sleep and psychiatric issues. He believes in optimization, not normalization, and devotes his work to optimizing brain health in professional athletes, executives, and anyone interested in peak performance. We did a deep dive into his book Peak Sleep Performance for Athletes: The Cutting-Edge Sleep Science That Will Guarantee a Competitive Advantage on EP 71[iv] so that, when he came on EP 72, we could maximize our time together, by asking the most practical questions to help all of us move the needle with our sleep. How did I come across Dr. Creado? I first heard him on Dr. Daniel Amen's Brain Warrior's Way Podcast, since he worked closely with Dr. Amen at that time. At that point I was just beginning to learn how to track and improve my own sleep. This conversation with him actually happened about a year before our interview with Dr. Kristin Holmes,[v] VP of Performance Science at WHOOP, and before I began officially measuring my sleep data with a wearable device. A few months after this interview, Dr. Creado reviewed my brain scan results from Dr. Amen's Clinics and told me that my brain showed the same pattern as someone who was sleep deprived (which we shared on EP 84[vi]). That feedback sent me searching for what else I could do to improve this crucial health staple: sleep. This episode opened the door for me to meet many other leaders in health and wellness and ultimately led to our deep dive into the six health staples that are scientifically proven to improve our mental and physical well-being. This was all years before our popular series on The Silva Method[vii] (still our most-listened-to series on this podcast), where we covered how to improve our creativity and innovation with sleep, and also before our review of The Fisher Wallace Brain Stimulator[viii] that held the top spot for years (with the topic of improving sleep). But it all really began with conversations like this one—with Dr. Shane Creado—on achieving peak performance with our sleep. So let's go back to March 2020 and revisit what Dr. Creado had to say about sleep.   VIDEO 1 – Click Here to Watch Dr. Creado reminds us that every cell in our body has its own circadian rhythm. When we understand this, it becomes clear what we need to do to support healthy sleep. He explains that historically, human sleep has been polymodal—people would sleep a few hours early in the night, wake for a bit, then sleep again in the early morning, and often nap in the afternoon. This pattern lines up with how melatonin behaves in the body: it rises at night, dips, and then shows a slight rise again in the afternoon. So when you feel sleepy after lunch, it's not just the food—it's your melatonin rising and your brain asking for a recharge. Key Takeaways from Dr. Shane Creado Dr. Creado challenges older sleep-hygiene advice that says to avoid naps altogether. In his words, that's “pretty much wrong.” Naps can be incredibly helpful—as long as you're strategic about them: Know how long you're going to nap Be deliberate about when and where you do it These are the keys to strategic napping, which we'll explore more as we revisit this powerful conversation. But first, let's put strategic napping into action. Put These Tips into Action 1. Keep Your Nap Between 10–20 Minutes (Power Nap) Short naps prevent you from dropping into deep sleep. This helps you wake up refreshed—not groggy—and boosts alertness, memory, and mood. 2. Use the 90-Minute Cycle Only When Needed A full 90-minute nap allows you to complete an entire sleep cycle. Use this only if you're: recovering from sleep debt jet-lagged coming off a night of fragmented sleep Avoid these longer naps late in the day. 3. Nap Before 3:00 PM Align your nap with the natural melatonin rise that occurs in the early afternoon. This prevents nighttime sleep disruption and supports your circadian rhythm. 4. Create a Consistent Nap Environment Set up conditions that your brain recognizes as “rest time”: dark or dim lighting comfortable temperature (lower temperatures are recommended) quiet or white noise reclining or lying down if possible Consistency trains the brain to drop into restorative rest efficiently. 5. Use a Caffeine Nap (If It Works for You) Drink a small amount of caffeine (like green tea or half a cup of coffee) immediately before a 10–20 minute nap. The caffeine kicks in right as you wake, giving you a double boost. 6. Set an Alarm Helps you avoid drifting into deep sleep and waking up groggy. This trains your brain to trust short naps and prevents oversleeping. 7. Observe Your Afternoon Melatonin Dip If you feel naturally sleepy between 1:00–3:00 PM, this is your biological nap window. Don't fight it—leverage it (if you can). 8. Don't Nap to Escape Stress Use napping as a performance tool, not an emotional coping mechanism. If you're lying down to escape anxiety, use breathwork or a 5-minute mindfulness break instead. 9. Track Your Sleep Response Everyone's nap sensitivity is unique. Track how naps affect your: nighttime sleep alertness mood work performance training or athletic performance If you want to dive deep, measure it: WHOOP, Oura, or any wearable can help determine your best nap duration and timing. 10. Combine Naps With Movement A short walk before or after a nap enhances the circadian benefit and clears residual grogginess. PUTTING THESE TIPS INTO ACTION: By now, we've all heard that napping is not a sign of laziness—it's a strategic tool for combating the sleep epidemic we're facing. Sleep deprivation can impair the brain as much as being under the influence, which is why even short, well-timed naps can play a powerful role in restoring our cognitive performance, mood, and overall health. I had to look to see what Matthew Walker[ix] (also known as the Sleep Diplomat) had to say about napping, compared to Dr. Creado's view, since I was studying both at the same time. If you look at this chart I've added in the show notes, you can see that Dr. Creado's philosophy helps you to nap for performance; (which makes sense to me since Dr. Creado advises athletes) and Matthew Walker helps you to nap without harming your nighttime sleep. His advice also made sense to me as he advises the general population, and the statistics don't lie. Most of us are sleep deprived. Both sleep experts believe in the power of taking naps, and they both lean towards napping for less than 20 minutes for power napping that avoids grogginess. While not all work environments are built to support this research, that surrounds napping before 3pm, there are companies that are embracing this research, you can Nap on the Job at These 10 Companies[x] Google PricewaterhouseCoopers Ben & Jerry's Cisco Potato Zappos Nike Uber White & Case Thrive Global If you like this option, you're in good company. Many organizations are already embracing future-focused workspaces with this research in mind. Arianna Huffington, now the founder of Thrive Global, has been one of the loudest voices calling attention to the sleep-deprivation crisis. She wrote the best-selling book The Sleep Revolution[xi] to highlight the science behind sleep and why our culture must change. Huffington points to research showing that naps boost the immune system, lower blood pressure, increase learning capacity, improve memory, and enhance our ability to perform complex tasks (Yahoo Finance). Companies adopting nap rooms and rest pods aren't being trendy—they're aligning their workplaces with well-established neuroscience and physiology. And this brings us full circle, because Dr. Shane Creado was emphasizing these same science-backed principles long before workplace culture caught up, showing us exactly how sleep—and even strategic napping—can become a powerful tool for peak performance. And here's where today's episode takes a powerful turn. We are going back to our MOST downloaded Series, The Silva Method, to now implement this method into Dr. Creado's tip for napping, to increase our creativity, innovation and productivity. The Silva Method & The 20-Minute Nap Where Creativity, Insight & Neuroscience Meet** Now that we know what to do from Dr. Creado's research—use short, strategic naps to support performance—the next step is to take this deeper and connect it to the most transformative tool that we've covered in our 7 years of hosting this podcast: The Silva Method. This is where the magic happens, as theory meets practice. What José Silva taught decades ago about guiding the brain into the Alpha state (a mental state of calm wakefulness, that is distinct from the high-frequency beta waves of a busy, alert mind) aligns perfectly with what neuroscience shows happens in a 20-minute nap. And it also explains why so many innovators—Einstein, Edison, Dalí, Tesla, Da Vinci—used structured micro-naps or “drifting states” to solve complex problems. They weren't just resting. They were deliberately entering the insight zone. Edison used metal balls to wake himself the moment he crossed into Theta (the brain state of deep relaxation that's a gateway to creativity, inspiration and new ideas). Dalí held a key over a plate for the same purpose. Einstein was known for multiple micro-naps throughout the day. Da Vinci mapped polyphasic sleep schedules to stay in that creative borderland between wake and sleep. They had discovered what both neuroscience and the Silva Method confirm: The moments between wakefulness and sleep—Alpha and early Theta—are the brain's most fertile ground for new ideas. **If you have not yet listened to the 4 PART SERIES on The Silva Method[xii], I highly encourage it as we do go into detail on HOW to start this practice, and learn how to train your brain to accomplish outstanding results that truly will shock you. How This Works? The Silva Method adds conscious intention. Before entering the Alpha, State you plant a question, problem, or intention—something that you want to solve, or learn more about. Then during the nap-like drift, the brain naturally reorganizes information, makes connections, and surfaces insights. When you return to Beta (full wakefulness), those insights often rise effortlessly. I've been doing this practice for 26+ years now, and I can tell you that it takes practice. In the beginning, I didn't have control of what was showing up on the screen of my mind during these short naps, and I had a difficult time understanding what certain things (or insight that were flashing on the screen of my mind) really meant. This will take practice, but it's well worth the time spent. A 20-minute nap and The Silva Method are using the same brain states—one intentionally, one biologically. Combined, they become a powerful creativity tool. Why This Works (Neuroscience + Silva) ✔ The brain enters Alpha/Theta — insight frequencies ✔ Cortisol drops — freeing cognitive resources ✔ The Default Mode Network activates — your “creative network” ✔ The nap resets your mental clarity ✔ The Silva Method gives the mind a specific task (whatever it is you are looking to solve). Together, they create a simple, natural protocol for breakthrough thinking. How To Use The Silva Method with a 20-Minute Nap to Improve Creativity? Here's a simple protocol that we can all use: Set an intention “Show me a solution for ___.” “Give me a creative idea for ___.” Enter Alpha (Silva Method) Use the 3–2–1 countdown or your preferred Silva relaxation method. Drift for 15–20 minutes You don't need full sleep—just hover between wake and sleep. Wake & Write Capture any images, ideas, feelings, or impressions immediately. This is truly one of the fastest ways to reset the brain, boost creativity, and spark intuition—because it aligns neuroscience with intention. The insights that you discover here are life-changing. Start writing down the ideas you “see” and “feel” and you will begin to find solutions to problems or ways forward in your daily life. VIDEO 2 Click Here to Watch Which brings us to our 2nd clip from Dr. Creado who reminds us about an important habit (that I have yet to master). Dr. Creado explains the deeper biological consequences of poor sleep with a powerful reminder: “If you immediately go to social media or your work emails as soon as you wake up, your cortisol levels are boosted even more. You go straight into danger mode and anxiety mode, and that's how you start your day.” He goes on to give an example many people don't realize the seriousness of: “Shift work actually causes fragmentation and breaks in your DNA. It sets people up for an increased risk of heart attacks and strokes. The World Health Organization has even designated shift work as a possible carcinogen—a cancer-causing behavior.” Most people think a few hours of lost sleep just makes them groggy or irritable, but as Dr. Creado explains, the consequences go much deeper: “This goes down to your very DNA. Sleep is your anchor. It can stave off aging. It can prevent obesity and inflammation. It can boost your immune system. It can delay menopause. It can upregulate testosterone and growth hormone levels, suppress stress hormones, and even regulate your gut flora.” This section reinforces the core theme of your episode: sleep is foundational biology—not a luxury—and optimizing it has ripple effects across every major system of the body. Key Takeaways from Dr. Shane Creado's 2nd Clip Avoid social media and emails immediately upon waking. They spike cortisol and activate “danger mode,” increasing anxiety from the moment your day begins. Shift work is biologically damaging. It fragments DNA, increases risk of heart attacks and strokes, and is recognized by the WHO as a possible carcinogen. Sleep is not optional—it's your biological anchor. It stabilizes your entire internal system, including mood, hormones, metabolism, and immunity. Poor sleep accelerates aging. Adequate sleep can slow (and even reverse) biological wear, protecting long-term health. Sleep regulates critical hormones. It boosts testosterone and growth hormone while reducing stress hormones like cortisol. Your gut depends on your sleep. Quality sleep helps maintain healthy gut flora, which influences everything from mood to inflammation to immunity. Put These Tips Into Action Here are simple, science-backed steps you can start today to optimize your sleep: 1. Protect the First 30 Minutes of Your Morning No social media No emails No news Use this time for grounding: hydration, sunlight, breathwork, or light movement. Dr. Creado is far from the only expert emphasizing this point—best-selling author Brendon Burchard includes it as one of his core High Performance Habits, reminding us that how we start our morning sets the tone for our entire day. 2. If You're a Shift Worker, Control What You Can Keep a consistent sleep–wake schedule when possible Use blackout curtains and cool temperatures Nap strategically to offset circadian disruption Prioritize sleep hygiene even more than daytime workers (This population is often overlooked. It came up with Dr. Creado, as well as with our interview with Kelly Roman how many people with shift work should be given extra support). 3. Build a Nighttime Routine That Signals “Safety” to the Brain Dim lights 60–90 minutes before bed Reduce screens Use calming cues: stretching, reading, warm shower, or meditation Keep a consistent bedtime 4. Use Strategic Napping to Lower Stress Hormones 10–20 minutes in the early afternoon Set an alarm to avoid deep-sleep grogginess A “caffeine nap” can boost alertness if well-tolerated 5. Strengthen Your Hormone Health Through Sleep Consistency Aim for 5–8.5 hours per night Regular sleep schedules support testosterone, growth hormone, and metabolic stability 6. Support Your Gut Through Rest Quality sleep = more balanced gut flora Try to eat your final meal 2–3 hours before bed Avoid heavy meals late at night 7. View Sleep as the Foundation for Everything Else Instead of seeing sleep as something to “fit in,” shift your mindset: Sleep is the strategy that makes all your other strategies work better. REVIEW AND CONCLUSION — Episode 378 PART 1 of our REVIEW with Dr. Shane Creado Key Insights From Video 1: Your Biology Wants You to Nap Dr. Creado reminded us that every cell in the body runs on its own circadian rhythm, and historically, humans slept in multiple phases—including early afternoon naps aligned with our melatonin's natural rise. He challenged outdated sleep-hygiene rules that discouraged napping and instead showed us how strategic naps—short, intentional, and well-timed—can restore energy and boost performance. We covered practical strategies for making napping work in real life, from 10–20 minute power naps to full 90-minute cycles when recovery is needed, emphasizing timing, environment, and consistency. Napping for Performance vs. Protecting Nighttime Sleep To deepen this topic, we compared Dr. Creado's approach with Matthew Walker's. Both agree that short naps (under 20 minutes) offer the best everyday benefits, though their philosophies differ: Creado teaches you to nap for performance, especially for athletes and high performers. Matthew Walker teaches you to nap without disrupting nighttime sleep, focusing on the general population. And while not all workplaces support napping, many leading companies now do—Google, Cisco, Zappos, Nike, Uber, PwC, and more—reflecting research championed by leaders like Arianna Huffington, who has long warned that sleep deprivation is a cultural crisis. Naps, she notes, improve immunity, blood pressure, learning, memory, and performance. Organizations adopting nap rooms aren't following a trend—they're following neuroscience. Key Insights From Video 2: Protect Your Morning Brain In our second clip, Dr. Creado warns about a habit many of us (including myself) struggle with: checking the phone immediately upon waking. This single behavior spikes cortisol and sends the brain into “danger mode,” setting the tone for an anxious, reactive day. He also described the biological risks of shift work—including DNA fragmentation and increased risk of heart attack and stroke—conditions serious enough that the WHO classifies shift work as a possible carcinogen. His message was clear: Sleep is your anchor. It affects aging, inflammation, immunity, hormone balance, and even gut health. Dr. Creado reminded us that sleep isn't a luxury—it's foundational biology. When we optimize sleep, we improve every system in the body: our hormones, immunity, focus, mood, and even our longevity. And when we take what he taught and combine it with the intentional practice of The Silva Method, we unlock something even more powerful. A simple 20-minute nap becomes more than rest—it becomes a doorway into the Alpha state where creativity, insight, and intuition live. This is why so many innovators throughout history used micro-naps to solve problems. The Silva Method simply adds conscious intention. And when we pair intention with the brain's natural rhythms, we create one of the most reliable pathways for breakthroughs. And watch how your best most innovative and creative ideas begin to rise to the surface.   With that thought, we will close out this episode, and we will see you next week, with PART 2 of our interview review with Dr. Creado. We have only scratched the surface of our review of this important health staple of sleep. See you next week.   REFERENCES: [i] Neuroscience Meets Social and Emotional Learning Podcast EPISODE #261 PART 1 of Apply the Silva Method for Improved Intuition, Creativity and Focus. https://andreasamadi.podbean.com/e/a-deep-dive-with-andrea-samadi-into-applying-the-silva-method-for-improved-intuition-creativity-and-focus-part-1/   [ii] Neuroscience Meets Social and Emotional Learning Podcast EPISODE #87 with Andrea Samadi on “The Top 5 Brain Health and Alzheimer's Prevention Strategies” https://www.achieveit360.com/the-top-5-brain-health-and-alzheimers-prevention-strategies-with-andrea-samadi/   [iii] Neuroscience Meets Social and Emotional Learning Podcast EPISODE #72 with Dr. Shane Creado on “Sleep Strategies that will Guarantee a Competitive Advantage.”  https://andreasamadi.podbean.com/e/dr-shane-creado-on-sleep-strategies-that-will-guarantee-a-competitive-advantage/   [iv] Neuroscience Meets Social and Emotional Learning Podcast EPISODE #71 with Dr. Shane Creado on “A Deep Dive into Dr. Creado's Peak Sleep Performance for Athletes”  https://andreasamadi.podbean.com/e/self-regulation-and-sleep-with-a-deep-dive-into-dr-shane-creados-peak-sleep-performance-for-athletes/   [v] Neuroscience Meets Social and Emotional Learning Podcast EPISODE 134 with Dr. Kristin Holmes, VP of Performance Science from Whoop.com https://andreasamadi.podbean.com/e/kristen-holmes-from-whoopcom-on-unlocking-a-better-you-measuring-sleep-recovery-and-strain/   [vi] Neuroscience Meets Social and Emotional Learning Podcast EPISODE 84 “Andrea's SPECT Image Brain Scan Results”  https://andreasamadi.podbean.com/e/how-a-spect-scan-can-change-your-life-part-3-with-andrea-samadi/   [vii] Neuroscience Meets Social and Emotional Learning Podcast EPISODE #261 PART 1 of Apply the Silva Method for Improved Intuition, Creativity and Focus. https://andreasamadi.podbean.com/e/a-deep-dive-with-andrea-samadi-into-applying-the-silva-method-for-improved-intuition-creativity-and-focus-part-1/   [viii] Neuroscience Meets Social and Emotional Learning Podcast EPISODE 120 “Andrea's Personal Review of The Fisher Wallace Wearable Medical Device for Anxiety, Depression and Sleep/Stress Management” https://andreasamadi.podbean.com/e/personal-review-of-the-fisher-wallace-wearable-medical-device-for-anxiety-depression-and-sleepstress-management/   [ix] https://www.sleepdiplomat.com/   [x] https://finance.yahoo.com/news/nap-job-10-companies-100300632.html   [xi] https://www.amazon.com/Sleep-Revolution-Transforming-Your-Night/dp/110190402X The Sleep Revolution, Published by Arianna Huffington April 4, 2017 [xii] Neuroscience Meets Social and Emotional Learning Podcast EPISODE #261 PART 1 of Apply the Silva Method for Improved Intuition, Creativity and Focus. https://andreasamadi.podbean.com/e/a-deep-dive-with-andrea-samadi-into-applying-the-silva-method-for-improved-intuition-creativity-and-focus-part-1/  

Forget everything you think you know about exercise and weight loss. The truth might surprise you—and it's backed by science.Ever found yourself grinding away on the treadmill while the scale refuses to budge? You're not alone. Exercise is often touted as the answer to weight loss, but the research tells a different story. A 400-calorie muffin takes two minutes to eat but 45 minutes of jogging to burn off. Our bodies are even programmed to compensate after workouts by increasing hunger and decreasing movement throughout the day.But don't cancel your gym membership just yet. Exercise shines as a powerful tool for maintaining weight loss and transforming health in ways the scale can't measure. Regular movement preserves muscle mass during weight loss, keeping your metabolism humming. It improves insulin sensitivity, regulates mood, reduces stress, and enhances sleep quality—all factors that indirectly support weight management by controlling stress eating and balancing hunger hormones.The sweet spot combines both cardio for heart health and strength training for muscle preservation. The World Health Organization recommends 150 minutes of moderate exercise weekly plus strength training twice weekly, though weight management may benefit from 250-300 minutes. The most sustainable approach? Find activities you genuinely enjoy, start small, and focus on consistency over intensity. Remember that non-exercise movement throughout the day (NEAT) often burns more calories than formal workouts, and beware of fitness trackers that overestimate calorie burn by 20-50%.Looking to transform your relationship with exercise? Stop viewing it as punishment for eating and start seeing it as a privilege—a way to build a stronger, more energetic body that will carry you through life. Pair smart nutrition with consistent movement, and you've created the most powerful strategy for long-term health and weight management. Want to learn more about plant-based nutrition and lifestyle medicine? Visit plantbaseddoctorjules.com for free resources to support your journey.Go check out my website for tons of free resources on how to transition towards a healthier diet and lifestyle.You can download my free plant-based recipes eBook and a ton of other free resources by visiting the Digital Downloads tab of my website at https://www.plantbaseddrjules.com/shopDon't forget to check out my blog at https://www.plantbaseddrjules.com/blog You can also watch my educational videos on YouTube at https://www.youtube.com/channel/UCMpkQRXb7G-StAotV0dmahQCheck out my upcoming live events and free eCourse, where you'll learn more about how to create delicious plant-based recipes: https://www.plantbaseddrjules.com/Go follow me on social media by visiting my Facebook page and Instagram accountshttps://www.facebook.com/plantbaseddrjuleshttps://www.instagram.com/plantbased_dr_jules/Last but not least, the best way to show your support and to help me spread my message is to subscribe to my podcast and to leave a 5 star review on Apple and Spotify!Thanks so much!Peace, love, plants!Dr. Jules

The Covid Inquiry led by Baroness Hallett has concluded that the UK did too little too late in response to Covid-19, that the lockdown could have been avoided if steps such as social distancing and isolating had been introduced earlier. Joining Anita Rani to give their response to the findings and tell their stories of that time, are musical theatre actor Ruthie Henshall, whose mother died in a care home during Covid and Naomi Fulop, from Covid-19 Bereaved Families for Justice UK, who also lost her mother during this time. Another chance to hear a shortened version of an interview Anita recorded last month with Melinda French Gates, the most well known and powerful woman in philanthropy. In 2000, Melinda co-founded the Bill and Melinda Gates Foundation, which has - to date - donated over one hundred billion dollars to charitable projects. She and Bill Gates married in 1994 and divorced in 2021, after 27 years of marriage. Melinda has since left their joint enterprise and set up her own, Pivotal Ventures, which has one purpose: to put power into the hands of women. In a new report 'Care, courage, change,' the World Health Organisation has conducted analysis of the various health and support policies for survivors of violence in the 53 countries of the WHO European Region. The report reveals that almost one in three women and girls aged 15-years and older, will experience physical or sexual violence in their lifetime - but countries' health sectors are failing nearly one in three survivors. Anita Rani talks to Melanie Hyde, WHO Europe's Gender, Equality and Human Rights Technical Officer, author of the report.Poetry, love and an incurable cancer diagnosis are the themes of a new film looking at the relationship between the acclaimed spoken word poet and activist Andrea Gibson and their wife, writer Megan Falley. Megan joins Anita along with the documentary's producer Jessica Hargrave to talk about the film and her late wife. Presenter: Anita Rani Producer: Rebecca Myatt

In this episode, host and producer of The Psychology of Self-Injury podcast, Dr. Nicholas Westers, shares his own thoughts about how media portray nonsuicidal self-injury (NSSI) as well as suicide and mass shootings. He walks us through media guidelines for responsibly reporting and depicting each in the news, including the first ever NSSI media guidelines he published with ISSS colleagues. This marks the second solo episode of the podcast.Media Guidelines:Suicide: Read the suicide reporting guidelines published by the World Health Organization (WHO) here, learn about ethical reporting guidelines for media put forth by the American Foundation for Suicide Prevention (AFSP) here, and visit reportingonsuicide.org to review those offered by Suicide Awareness Voices of Education (SAVE).Mass Shootings: Read about media guidelines for responsible reporting on mass shootings put forth by the Radio Television Digital News Association (RTDNA) at www.rtdna.org/mass-shootings or visit reportingonmassshootings.org (this link is not currently active but could be reactivated in the future).Nonsuicidal Self-Injury (NSSI): Read about our International Society for the Study of Self-Injury (ISSS) media guidelines for NSSI and self-harm below. Watch Dr. Westers' interview with the British Journal of Psychiatry, the journal that published these guidelines here. See excellent resources provided by the Self-Injury & Recovery Resources (SIRR) at Cornell University at selfinjury.bctr.cornell.edu, including resources for the media here. Below are additional resources referenced in this episode.Westers, N. J., Lewis, S. P., Whitlock, J., Schatten, H. T., Ammerman, B., Andover, M. S., & Lloyd-Richardson, E. E.(2021). Media guidelines for the responsible reporting and depicting of non-suicidal self-injury. The British Journal of Psychiatry, 219(2), 415-418.Westers, N. J. (2024). Media representations of nonsuicidal self-injury. In E. E. Lloyd-Richardson, I. Baetens, & J. Whitlock (Eds.), The Oxford handbook of nonsuicidal self-injury (pp. 771-786). Oxford University Press.Phillips, D. P. (1974). The influence of suggestion on suicide: Substantive and theoretical implications of the Werther effect. American Sociological Review, 39(3), 340–354.Niederkrotenthaler, T., Voracek, M., Herberth, A., Till, B., Strauss, M., Etzersdorfer, E., Eisenwort, B., & Sonneck, G. (2010). Role of media reports in completed and prevented suicide: Werther v. Papageno effects. The British Journal of Psychiatry, 197(3), 234– 243.Follow Dr. Westers on Instagram and Twitter/X (@DocWesters). To join ISSS, visit itriples.org and follow ISSS on Facebook and Twitter/X (@ITripleS).The Psychology of Self-Injury podcast has been rated as one of the "10 Best Self Harm Podcasts" and "20 Best Clinical Psychology Podcasts" by Feedspot  and one of the Top 100 Psychology Podcasts by Goodpods. It has also been featured in Audible's "Best Mental Health Podcasts to Defy Stigma and Begin to Heal."

Far from a future add-on, artificial intelligence is already embedded in the cycle of drug safety, from case processing to signal detection. Versatile generative AI models have raised the bar of possibilities but also increased the stakes. How do we use them without losing trust and where do we set the limits?In this two-part episode, Niklas Norén, head of Research at Uppsala Monitoring Centre, unpacks how artificial intelligence can add value to pharmacovigilance and where it should – or shouldn't – go next.Tune in to find out:How to keep up with rapid developments in AI technologyWhy model and performance transparency both matterHow to protect sensitive patient data when using AIWant to know more?Listen to the first part of the interview here.In May 2025, the CIOMS Working Group XIV drafted guidelines for the use of AI in pharmacovigilance. The draft report received more than a thousand comments during public consultation and is now being finalised.Earlier this year, the World Health Organization issued guidance on large multi-modal models – a type of generative AI – when used in healthcare.Niklas has spoken extensively on the potential and risks of AI in pharmacovigilance, including in this presentation at the University of Verona and in this Uppsala Reports article.Other recent UMC publications cited in the interview or relevant to the topic include:a pre-print on the revised vigiMatch algorithm for duplicate detectionan article on the pitfalls of disproportionality analysisa pre-print on critically appraising AI applications for rare-event recognitionFor more on the ‘black box' issue and maintaining trust in AI, revisit this interview with GSK's Michael Glaser from the Drug Safety Matters archive. Join the conversation on social mediaFollow us on Facebook, LinkedIn, X, or Bluesky and share your thoughts about the show with the hashtag #DrugSafetyMatters.Got a story to share?We're always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!About UMCRead more about Uppsala Monitoring Centre and how we promote safer use of medicines and vaccines for everyone everywhere.

There are calls for a public awareness and education campaign about domestic violence, after fresh data has revealed its prevalence around the globe. A new report from the World Health Organisation says a quarter of women have experienced intimate partner sexual or domestic violence in their lifetime. Lauren Crimp has more.

Focus: Black Oklahoma's Venson Fields turns our attention to the Supplemental Nutrition Assistance Program, or SNAP, benefits crisis. Tens of thousands of families across the state are still feeling the ripple effects of the government shutdown—not in abstract political terms, but in their kitchens and on their dinner tables. At the University of Central Oklahoma, student journalists at The Vista have found their independence and integrity under fire, facing administrative pressures that echo the chilling precedents set at places like the University of Missouri, or Mizzou. These moments raise urgent questions about who gets to tell the story, whose voices are heard, and what happens to democracy when student press freedom is stifled. Nico Berlin takes a closer look at the growing wave of attacks on free speech across college campuses—right here at home and across the nation. In May of this year, the Oklahoma Department of Mental Health and Substance Abuse Services revealed a 30 million dollar budget shortfall, which required an emergency appropriation by the state legislature. In September, the legislature announced hundreds of contracts would not be renewed to address the department's budget going forward. FBO's Alana Mbanza explores the human costs of these cuts.According to the World Health Organization, “Everyone, if they live long enough, will experience at least one eye condition in their lifetime that will require appropriate care.” An estimated 2.2 billion people, or a quarter of the world's population, live with visual impairment or blindness. In the town of Kinondo in Kenya, multiple organizations came together to provide vision care during World Blindness Month. Zaakirah Muhammad has details.A year after the opening of Zink Lake in Tulsa, questions continue to surface about the safety and quality of water in the Arkansas River. FBO's Roma Carter spoke with independent journalist Molly Bullock about her coverage of waterway contamination.For generations, African American musicians have turned rhythm into revolution—using their art to challenge racism, economic oppression, and social injustice. From gospel to hip-hop, protest songs to soul anthems, Francia Allen continues her series on music & culture as she traces how music continues to impact both hearts and movements, amplifying the call for freedom, dignity, and a world grounded in love.Finally, we pause to remember. This poem, written by Brooks Lansana, invites us into a space of reflection—of memory and reverence—for those whose names were never spoken, whose stories were buried beneath the ashes of the 1921 Tulsa Race Massacre. Focus: Black Oklahoma is produced in partnership with KOSU Radio & Tri-City Collective. Additional support is provided by the Commemoration Fund & Press Forward. Our theme music is by Moffett Music. Focus: Black Oklahoma's executive producers are Quraysh Ali Lansana & Bracken Klar. Our associate producers are Jesse Ulrich, & Naomi Agnew.You can visit us online at KOSU.org or FocusBlackOklahoma.com & on YouTube @TriCityCollectiveOK. You can follow us on Instagram @FocusBlackOK & on Facebook at Facebook.com/FocusBlackOK. You can hear Focus: Black Oklahoma on demand at KOSU.org, the NPR app, NPR.org, or wherever you get your podcasts. https://linktr.ee/focusblackok

The US Congress has voted nearly unanimously to force the release of all unclassified Justice Department files, related to the late convicted sex offender Jeffrey Epstein; Tropical Cyclone Fina has officially formed off the Northern Territory's Top End coast, intensifying overnight from a tropical low; A 25-year-old woman has died after a suspected mass poisoning at the Clandestino Hostel in Canggu, Bali; The World Health Organisation is set to reduce its global workforce by nearly a quarter, by June 2026 as it implements major reforms following the announced departure of its largest donor, the United States; Magda Szubanski, the beloved star of Kath & Kim, is reportedly maintaining her trademark humour and upbeat spirit six months after being diagnosed with aggressive Stage 4 Mantle Cell Lymphoma. Support independent women's media CREDITS Host/Producer: Gemma Donahoe Audio Production: Lu HillBecome a Mamamia subscriber: https://www.mamamia.com.au/subscribeSee omnystudio.com/listener for privacy information.

This week on The Broski Report, Fearless Leader Brittany Broski answers journal prompts, discusses the age of brainrot, and analyzes trends in the horror genre. Watch The Broski Report AD FREE: https://patreon.com/broskireport  The OFFICIAL Songs of The Week Playlist: https://open.spotify.com/playlist/3ULrcEqO2JafGZPeonyuje?si=061c5c0dd4664f01 

PREVIEW Janatyn Sayeh highlights the severe, unacceptable air quality and pollution crisis in Tehran, where she grew up. The pollution is described as poison, with carbon dioxide levels reported to be ten times higher than the World Health Organization's recommended average. The pollution is so severe that schools are sometimes shut down during winter, and residents constantly smell and ingest the high carbon dioxide levels. Guest: Janatyn Sayeh. 18TH CENTURY TEHRAN

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: It's World Diabetes Day and we have a LOT of news to get to! Daily oral insulin tested to prevent T1D, mothers and sons and a T1D link, stem cell updates, Tandem Android news, Omnipod's workplace campaign and more! Find out how to submit your Community Commercial Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. It's world diabetes day! It is marked every year on 14 November, the birthday of Sir Frederick Banting, who co-discovered insulin along with Charles Best in 1922.   WDD was created in 1991 by International Diabetes Federation (IDF) and the World Health Organization and became an official United Nations Day in 2006 with the passage of United Nations Resolution 61/225. There will be a ton of stuff in your feeds today and that's great! I'm going to keep this to a pretty normal in the news episode.. although I do have my own World Diabetes Day announcement – I want YOUR community commercials. You could have an ad for your event or your blog or your project right here! There's a post on the website explaining it all and I'll come back at the end of the episode and tell you more. XX The Primary Oral Insulin Trial (POInT) is the first large-scale clinical trial to test whether giving at-risk children daily oral insulin could prevent or delay type 1 diabetes (T1D). Conducted by researchers from Helmholtz Munich and the Technical University of Munich across five European countries, the study enrolled more than 1,000 children with a genetic risk for T1D. Results published in The Lancet show that while oral insulin did not prevent the development of islet autoantibodies—an early sign of diabetes—it was safe and well tolerated. Importantly, researchers found that some children who received oral insulin developed diabetes more slowly than those given a placebo, suggesting potential protective effects in certain genetic subgroups.   Further analysis revealed that the response to treatment depended on the child's insulin gene variant. Children with genetic versions that raise diabetes risk appeared to benefit, showing delayed onset of the disease, while those without the risk variant did not. These findings point toward a future of personalized prevention, where genetic screening could help identify which children might benefit most from oral insulin. Researchers will continue following the participants until age 12 to assess long-term effects. The study marks a major milestone in decades of diabetes prevention research, highlighting both the promise and complexity of developing tailored, early interventions against type 1 diabetes. XX Joint US-Chinese research looking at generating new beta cells from stomach cells. Upon turning on the "genetic switch," the human stomach cells were converted to insulin-secreting cells within the mice and resembled pancreatic beta cells with respect to gene and protein expression. Encouragingly, when those experiments were done with diabetic mice, insulin secreted from the transformed human cells helped control blood sugar levels and ameliorated diabetes. The scientists hope that a similar approach can be taken to convert cells from a patient's own stomach into insulin-secreting cells directly within the body. Importantly, additional studies are needed to address if this approach is safe and effective to be used in patients. https://www.technologynetworks.com/cell-science/news/human-stomach-cells-tweaked-to-make-insulin-406694 XX A new study in Nature Metabolism may help explain why children born to mothers with type 1 diabetes are less likely to develop the disease early in life compared to those whose fathers or siblings have it. Researchers looked at nearly 2,000 mothers and their children and found that  kids whose moms have type 1 diabetes show changes in their DNA that may actually help protect them. These aren't genetic mutations, but epigenetic changes — chemical tags that turn certain genes on or off. The study found these changes in genes tied to the immune system and type 1 diabetes risk, suggesting that a mother's condition during pregnancy can shape her child's immune response in a protective way. Scientists identified more than 500 areas of DNA where these changes occurred, many in regions that control how the body's immune system works. Most of the changes appeared to calm down the kind of overactive immune response that leads to type 1 diabetes. Researchers even created a "methylation score" to help measure this protective effect. They say the next step is to confirm these results in more diverse groups and figure out exactly how these DNA changes help prevent early diabetes. https://www.news-medical.net/news/20251110/Maternal-type-1-diabetes-may-protect-children-from-developing-the-disease.aspx XX A new study from Karolinska Institutet and Stockholm University reveals that sons born to mothers with type 1 diabetes may develop early vascular dysfunction—independently of metabolic health. The finding may help shape future strategies to prevent cardiovascular disease early in life.     Children of women with type 1 diabetes are known to be at increased risk of developing cardiovascular diseases. This new study, published in Cell Reports Medicine, is the first to show that the risk is linked to early dysfunction in blood vessel cells in sons, even before any metabolic issues arise. The team is now investigating the long-term effects of maternal diabetes, with a particular focus on why sons seem to be affected earlier than daughters. https://medicalxpress.com/news/2025-11-sons-mothers-diabetes-early-vascular.html XX A new study presented at Kidney Week 2025 has shown that the drug finn-uh-near-own  a nonsteroidal mineralocorticoid-receptor antagonist, significantly reduced albuminuria—a key marker of kidney damage—in people with type 1 diabetes (T1D) and chronic kidney disease (CKD). This is the first major breakthrough for this population in more than 30 years. Researchers found that patients taking finerenone saw a 25% average reduction in albuminuria compared to placebo, an improvement that suggests a lower long-term risk for dialysis or kidney transplant. The phase 3 FINE-ONE trial involved 242 adults with T1D and CKD, and results showed benefits as early as three months. The drug was generally well tolerated, with side effects similar to those seen in patients with type 2 diabetes, though mild hyperkalemia (high potassium levels) was slightly more common. Experts say the findings could change the way doctors treat kidney complications in type 1 diabetes, an area that hasn't seen new therapies since the early 1990s. Currently, treatment options rely on blood pressure and blood sugar management, along with renin-angiotensin system (RAS) inhibitors. Finerenone, which is already approved for type 2 diabetes-related CKD, targets overactivation of a receptor that drives kidney damage. Based on these results, Bayer plans to seek FDA approval in 2026 for use in people with T1D and CKD. Researchers and clinicians alike are calling the study "groundbreaking," noting that it opens the door to future research on how finerenone might not just slow kidney decline—but possibly prevent it altogether. https://www.medscape.com/viewarticle/finerenone-offers-hope-kidney-disease-type-1-diabetes-2025a1000uzi?form=login   XX This week, Tandem Diabetes Care (Nasdaq:TNDM) announced a major milestone for its Mobi miniature durable insulin pump system. San Diego-based Tandem revealed that it received FDA approval for the Android version of its Mobi mobile app. Clearance brings Mobi — which the company describes as the world's smallest, durable automated insulin delivery system — to more users. The pump, which pairs with Tandem's Control-IQ+ algorithm, previously worked with iOS software.   Tandem — one of the largest diabetes tech companies in the world — expects to begin a limited rollout next month, followed by full commercial availability in early 2026. This marks the latest milestone for the company, which continues to expand its offerings and widen its reach within the diabetes patient population.   We had a great interview with Tandem on our previous episode, but as I said at the time, it was coming before their earnings call. So here's an update: The company plans to submit the tubeless mobi to the fda before the end of this year.. possible approval and shipping date is hoped for by middle of 2026. Trials for their fully closed loop next-generation algorithm which we tlkaed abou ton the show should be launched in 2026 The Sigi patch pump will be developed and launched as a next-generation version of the Mobi Great job by Dr. David ? Ahn – he posted on IG after getting a message from tandem CEO John Sheridan? 1. First, the Tandem X3 *is* still absolutely in development, contrary to my speculation In yesterday's video. As many of you appropriately pointed out, there is definitely a market for a 300 unit pump, a pump with a screen, and a pump that does not require smartphone control. So from our brief chat, the sense I got that is that the X3 would be more of a refresh of the X2 with newer components, such as a USB-C connector and better memory, rather than a total redesign from the ground up. In terms of timing, all I could get was that it was "not too far distant in the future," which could mean anything I guess, but at least it's still on the way! 2. Next up, he also reassured me that they are working closely with Dexcom to support the G7 15 Day sensor within the next few months. I suspected as much, but it's always good to hear confirmation. 3. Lastly, he did confirm that Tandem is far along in developing a Caregiver/Follow app to allow the remote viewing of glucose and insulin data from a Tandem pump. He explained that it will be based on Sugarmate, the popular diabetes data dashboard app that Tandem acquired back in Jun 2020. While I don't know if every feature will make it into the Tandem caregiver app, Sugarmate is well-liked for its highly customizable dashboard and highly configurable alerts. Sugarmate even has the option to send a text message or phone call for urgent lows. Regardless, a true follow/Caregiver app will be welcomed with open arms by all caregivers and Tandem users who use Libre 3 Plus. https://time.com/7318020/worlds-top-healthtech-companies-2025/ XX Senseonics submits Eversense 365 – their year long implantable CGM for a CE mark, European Approval and expect to launch there soon. Eversense will be integrated with the sequel twist pump – again I'm hearing soon but no timeline. Intersting to note that one year inseration was approved in the US just about a year ago, so the first patients will be having their CGMs changed out – for the first time – pretty soon. https://www.drugdeliverybusiness.com/senseonics-q2-2025-sales-beat-ce-mark/ XX A confusing study out of Rutgers - these researcher say  metformin reduces some of the key benefits normally gained from regular physical activity. These include improvements in blood vessel health, physical fitness, and the body's ability to regulate blood sugar. Since 2006, doctors have typically encouraged patients with elevated blood sugar levels to combine metformin with exercise, expecting that the two proven treatments would produce stronger results together. However, the new research suggests this may not be the case. In this study, Exercise alone improved vascular insulin sensitivity, meaning blood vessels responded better to insulin and allowed more blood flow to muscles. This matters because insulin's ability to open blood vessels helps shuttle glucose out of the bloodstream and into tissues, lowering blood sugar after meals. But when metformin was added, the improvements shrank. The drug also diminished gains in aerobic fitness and reduced the positive effects on inflammation and fasting glucose. The findings don't mean people should stop taking metformin or exercising, Malin said. Instead, it raises urgent questions for doctors about how the two treatments can be combined and the need for close monitoring. Malin hopes future research will uncover strategies that preserve the benefits of both. https://scitechdaily.com/popular-diabetes-drug-metformin-may-cancel-out-exercise-benefits-study-warns/ XX XX https://www.medtechdive.com/news/Revvity-Sanofi-diabetes-test-Kihealth-seed-round/802133/   XX Dexcom recalled an Android app for its G6 glucose sensor due to a software problem that could cause the app to terminate unexpectedly. The issue could cause users to miss alarms, alerts or notifications related to estimated glucose values, according to a Food and Drug Administration database entry posted Oct. 30. The glucose sensor and the app are still available, but Dexcom required users to update the app to a new version. Dexcom began the recall on Aug. 28. The FDA designated the event as a Class 1 recall, the most serious kind. Dexcom sent a notification to customers in September about the software bug, which applies to version 1.15 of the G6 Android app. To use the app, customers must update it to a new version, according to the entry. https://www.medtechdive.com/news/dexcom-recall-g6-cgm-app/804630/ XX https://www.medscape.com/viewarticle/automated-insulin-delivery-boosts-glycemic-control-youth-2025a1000ub3 XX Tidepool partners with smart ring maker OURA.. press release says: to support a groundbreaking dataset intended to be broadly available for diabetes research, with participation limited to individuals who opt in through Tidepool.         Tidepool will pair biometric data from Oura Ring – sleep, activity, heart rate, temperature trends, and menstrual cycles – with diabetes device data, including continuous glucose monitors (CGMs) and insulin pumps. The result will provide researchers with an unprecedented dataset to accelerate the development of new clinical guidelines, next-generation diabetes technology, and personalized care models.   Recruitment is expected to launch in early 2026 through an IRB-approved study. By opting in to this study, participants consent to sharing their data with Tidepool's Big Data Donation Project, where data is de-identified and, with participant consent, shared with academics, researchers, and industry innovators to accelerate diabetes research. https://aijourn.com/tidepool-collaborates-with-oura-to-advance-inclusive-diabetes-research-through-wearables/ XX Eli Lilly launches two new clinical trials for baricitinib. These phase 3 trials will investigate whether the drug can delay T1D onset or progression and will open for recruitment soon. Baricitinib has the potential to extend the "honeymoon period" of T1D, meaning that it could preserve remaining insulin-producing beta cells earlier in disease progression. More beta cells mean better blood sugar management—and potentially reduced long-term complications. JAK inhibitors, including baricitinib, are already FDA-approved for other autoimmune diseases, such as rheumatoid arthritis, alopecia, and more. JAK signaling pathways are associated with overactive immune responses, so blocking this pathway may turn down the immune response. The phase 2 Breakthrough T1D-funded BANDIT study was key in showing that this drug is safe and effective in T1D. Importantly, baricitinib is a once-daily oral pill—meaning its use is simple and easy.   https://www.breakthrought1d.org/news-and-updates/two-new-trials-baricitinib-to-delay-t1d/ XX   Insulet is taking diabetes awareness into the workplace. Having found 79% of people with diabetes have faced bias or misunderstanding at work, the medtech giant is rolling out a range of resources intended to trigger changes in how workplaces approach the condition. Lots going on for Diabetes Awareness month.. some notables.. Insulet's "The Day Diabetes Showed up to Work" campaign. based on a survey of almost 10,000 people 79% of people with diabetes have faced bias or misunderstanding at work,.   Almost 90% of people with diabetes surveyed reported experiencing barriers at work due to their condition, and more than 40% of people with diabetes and caregivers said they have workplace-related anxiety tied to the metabolic disease. Around one-quarter of respondents reported fears that diabetes could limit opportunities or lead to workplace discrimination and judgment, and a similar proportion of people said they conceal their condition. https://www.fiercepharma.com/marketing/widespread-workplace-challenges-people-diabetes-spark-insulet-campaign XX New directive issued by the Trump administration could mean people seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or obesity.   The guidance, issued in a cable the State Department sent to embassy and consular officials and examined by KFF Health News, directs visa officers to deem applicants ineligible to enter the U.S. for several new reasons, including age or the likelihood they might rely on public benefits.   The guidance says that such people could become a "public charge" — a potential drain on U.S. resources — because of their health issues or age.   The cable's language appears at odds with the Foreign Affairs Manual, the State Department's own handbook, which says that visa officers cannot reject an application based on "what if" scenarios, Wheeler said.   The guidance directs visa officers to develop "their own thoughts about what could lead to some sort of medical emergency or sort of medical costs in the future," he said. "That's troubling because they're not medically trained, they have no experience in this area, and they shouldn't be making projections based on their own personal knowledge or bias."   Immigrants already undergo a medical exam by a physician who's been approved by a U.S. embassy. https://www.npr.org/2025/11/12/nx-s1-5606348/immigrants-visas-health-conditions-trump-guidance XX SAN DIEGO---Nov. 14, 2025—DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today unveiled 16 new diabetes advocates to represent people living with diabetes globally as part of Dexcom's World Diabetes Day campaign. The advocates – ranging from ages six to 68, spanning various types of diabetes, and hailing from four continents and five countries – were selected from 1,000 open call submissions based on their experiences advocating for people with diabetes in their communities. While each person's experience with diabetes is unique, they share a common passion for advocacy – and use of Dexcom's glucose biosensing technology. "Through advocacy, I strive to show others, especially children and newly diagnosed patients, that diabetes is not a limitation but an opportunity to grow stronger, inspire resilience and pursue ambitious goals," said Maria Alejandra Jove Valerio, one of Dexcom's new advocates. "What began as a diagnosis at age seven has grown into a lifelong mission to uplift others." This effort represents the first time Dexcom has sourced voices from the broader diabetes community specifically for its World Diabetes Day campaign, reinforcing Dexcom's history of and commitment to giving real people with diabetes a platform to share their story on a global stage. Through engaging, editorial-style portraits and deeply personal stories, the campaign highlights each advocate's personal experience with diabetes, what misconceptions about diabetes they'd like to dispel and how they want to inspire others with diabetes to discover what they're made of. To prepare for the spotlight, the group of advocates met in Los Angeles for a World Diabetes Day photoshoot which included a surprise visit from Grammy-nominated artist, actor, producer and Dexcom Warrior Lance Bass and author, producer, actress and Stelo*Ambassador Retta. This visit offered the advocates an opportunity to exchange stories and personal perspectives on the meaning of diabetes advocacy and how they live it each day. Behind the lens at the shoot was another member of the diabetes community—photographer Tommy Lundberg who lives with Type 1 diabetes. "Directing this photoshoot was nothing short of inspiring. Each of these advocates has a unique an XX On what would have been the 100th birthday of its visionary founder Alfred E. Mann, MannKind Corporation (Nasdaq: MNKD), in partnership with Alfred E. Mann Charities and The Diabetes Link, announced the launch of the Centennial Al Mann Scholarship. The new program will distribute $100,000 in scholarship funds to support at least 10 young adult students living with diabetes as they pursue higher education in life sciences.   Launched in Diabetes Awareness Month, the scholarship program honors Alfred E. Mann's enduring legacy of innovation, philanthropy, and his lifelong commitment to improving the quality of human life through medical advancement. Deeply passionate about giving back, Mr. Mann believed that his success should continue to serve humanity long after his passing, a belief that lives on through this initiative.   Each scholarship recipient will be awarded up to $10,000, distributed in annual installments of $2,500 throughout the course of their studies. Depending on the length of their degree program, recipients may receive between two and four installments (up to the full $10,000 per student). The first awards will be made for the 2026 academic year.   "Al Mann dedicated his life to helping people with serious medical conditions live longer, healthier lives. This scholarship is a reflection of that spirit," said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. "By supporting students living with diabetes who are pursuing careers in the life sciences and adjacent fields, we're honoring Al's legacy and investing in the future of innovation and care. This program is about giving back to the community we serve and empowering the next generation to carry forward Al's mission of making a meaningful difference in people's lives."   Alfred E. Mann Charities and MannKind will partner with The Diabetes Link to launch the program to serve young adults (aged 18-22) living with either type 1 or type 2 diabetes with their higher education goals. Those eligible will include incoming freshmen and current students pursuing 2- or 4-year degrees. The application window will open in early 2026, and for those interested in receiving notifications, an early interest form is available. More information about the scholarship will be shared on thediabeteslink.org.   "We're honored to partner with MannKind to expand access to higher education for young adults with diabetes," said Manuel Hernández, Chief Executive Officer of The Diabetes Link. "At a time when the cost of college continues to rise, this scholarship helps ease the financial burden and carries forward the spirit of Al Mann, whose vision and legacy continue to inspire us."   Mr. Mann was MannKind's Chairman of the Board from 2001 until his passing in February 2016 and served as Chief Executive Officer from November 2003 until January 2015. Driven by a desire to improve lives and fill unmet medical needs, for more than six decades he founded 17 companies and developed breakthrough medical devices, including insulin pumps, cochlear implants, cardiac pacemakers and retinal prostheses. In 1997, Mr. Mann saw the potential of a dry powder insulin formulation to change the way diabetes is treated and invested nearly $1 billion to help bring Afrezza® (insulin human) Inhalation Powder to market.   About MannKind MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.   With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.   Learn more at mannkindcorp.com.   About Alfred E. Mann Charities, Inc. Alfred E. Mann Charities, Inc. became active in 2016, following the passing of the organization's benefactor, Alfred E. Mann. Throughout his life, Al was passionate about philanthropy and was dedicated to prolonging and improving the quality of human lives through innovation in the fields of healthcare and the use of medical devices. It was important to Al that his success and assets continue to better human lives even after his own passing.   Alfred E. Mann Charities, Inc. (formerly known as Alfred E. Mann Family Foundation) has similarly placed its primary focus on healthcare and medical innovation, as our organization believes this is where we can have the greatest impact on humanity and human health throughout the world. Alfred E. Mann Charities, Inc. is also dedicated to promoting arts, culture, education, and community development across Los Angeles and throughout the world in order to best serve people and this planet.   Learn more at aemanncharities.org.   About The Diabetes Link The Diabetes Link is the only national nonprofit organization dedicated to empowering young adults living with diabetes. Founded by and for young adults, The Link serves this community through peer support, leadership opportunities, and practical, evidence-based resources designed for real life. Its network of campus and community chapters, active online community, and robust Resource Hub help young adults navigate the transitions of early adulthood while managing diabetes. The organization envisions a future where every young adult living with diabetes has

How much plastic are we actually absorbing and what's it doing to our health?In this eye-opening episode, I'm joined by Dr. Stephanie Wright, one of the UK's leading scientists in microplastic research, to explore what happens when plastic pollution doesn't just affect the environment, but our bodies too.We dive into:

This week on The Broski Report, Fearless Leader Brittany Broski recaps a recent girls trip, reads her own Oracle cards, and hosts book club.  Watch The Broski Report AD FREE: https://patreon.com/broskireport  The OFFICIAL Songs of The Week Playlist: https://open.spotify.com/playlist/3ULrcEqO2JafGZPeonyuje?si=061c5c0dd4664f01 

This week on The Broski Report, Fearless Leader Brittany Broski discusses Guillermo Del Toro's Frankenstein and immortality.  Watch The Broski Report AD FREE: https://patreon.com/broskireport  The OFFICIAL Songs of The Week Playlist: https://open.spotify.com/playlist/3ULrcEqO2JafGZPeonyuje?si=061c5c0dd4664f01 

NYC Election, Famine Propaganda, and Foreign Influence on Campus. Malcolm Hoenlein discusses the New York City mayoral election, focusing on the populist rise of candidate Zelldin Maamoun, whose anti-Israel stance and lack of economic knowledge threaten the city's large Israeli-founded tech sector. He reveals that a World Health Organization official admitted that promoting "famine" in Gaza was a deliberate communications and political pressure strategy, despite adequate food supply. Hoenlein confirms that Hezbollah is rearming and refashioning ordnance in Lebanon, forcing Israel's hand. University leaders have begun acknowledging that campus unrest was largely foreign-driven, specifically citing Iran. Indonesia is noted as a potential key player in future Abraham Accords. 1949 STORK CLUB MYRA DELL AND JOLTIN' JOE

NYC Election, Famine Propaganda, and Foreign Influence on Campus. Malcolm Hoenlein discusses the New York City mayoral election, focusing on the populist rise of candidate Zelldin Maamoun, whose anti-Israel stance and lack of economic knowledge threaten the city's large Israeli-founded tech sector. He reveals that a World Health Organization official admitted that promoting "famine" in Gaza was a deliberate communications and political pressure strategy, despite adequate food supply. Hoenlein confirms that Hezbollah is rearming and refashioning ordnance in Lebanon, forcing Israel's hand. University leaders have begun acknowledging that campus unrest was largely foreign-driven, specifically citing Iran. Indonesia is noted as a potential key player in future Abraham Accords. 1950 STORK CLUB, HITCHCOCK AND LAMOUR

SHOW 11-3-25 CBS EYE ON THE WORLD WITH JOHN BATCHELOR 1895 TRINIDAD THE SHOW BEGINS IN THE DOUBTS ABOUT VENEZUELA. FIRST HOUR 9-915 Middle East Disorder, Gaza Ceasefire, and Lessons from War Reporting. Bill Roggio and Husain Haqqani address the persistent disorder in the Middle East, noting that the Gaza ceasefire ("hudna") is only a pause. Ambassador Haqqani critiques the flawed concept of pursuing a "war to end all wars," suggesting the world is a situation to endure, not solve permanently. Bill Roggio compares the current stabilization efforts to the failed attempts in Afghanistan following the Taliban's ouster, noting that key players like Hamas remain undefeated or unwilling to disarm. Both experts stress the difficulty of verifying initial reports of mass violence, urging patience and skepticism regarding premature assumptions about perpetrators or motivations. 915-930 Middle East Disorder, Gaza Ceasefire, and Lessons from War Reporting. Bill Roggio and Husain Haqqani address the persistent disorder in the Middle East, noting that the Gaza ceasefire ("hudna") is only a pause. Ambassador Haqqani critiques the flawed concept of pursuing a "war to end all wars," suggesting the world is a situation to endure, not solve permanently. Bill Roggio compares the current stabilization efforts to the failed attempts in Afghanistan following the Taliban's ouster, noting that key players like Hamas remain undefeated or unwilling to disarm. Both experts stress the difficulty of verifying initial reports of mass violence, urging patience and skepticism regarding premature assumptions about perpetrators or motivations. 930-945 Post-Ceasefire Gaza Hostages and Hezbollah Regeneration in Lebanon. David Daoud and Bill Roggio discuss how following the Gaza ceasefire, the process of returning remains of slain hostages remains delayed, which Daoud suggests Hamas uses as leverage to prevent Israel from resuming conflict and entrenching a "post-war mentality." Experts note that Hezbollah is actively regenerating its military capabilities in Lebanon, bypassing disarmament efforts. Despite continuous, targeted Israeli strikes against Hezbollah personnel, there is minimal international condemnation because the organization maintains overwhelming Shiite support and the Lebanese government fails to enforce disarmament. Plans for an international security force in Gaza remain vague. 945-1000 Post-Ceasefire Gaza Hostages and Hezbollah Regeneration in Lebanon. David Daoud and Bill Roggio discuss how following the Gaza ceasefire, the process of returning remains of slain hostages remains delayed, which Daoud suggests Hamas uses as leverage to prevent Israel from resuming conflict and entrenching a "post-war mentality." Experts note that Hezbollah is actively regenerating its military capabilities in Lebanon, bypassing disarmament efforts. Despite continuous, targeted Israeli strikes against Hezbollah personnel, there is minimal international condemnation because the organization maintains overwhelming Shiite support and the Lebanese government fails to enforce disarmament. Plans for an international security force in Gaza remain vague. SECOND HOUR 10-1015 NYC Election, Famine Propaganda, and Foreign Influence on Campus. Malcolm Hoenlein discusses the New York City mayoral election, focusing on the populist rise of candidate Zelldin Maamoun, whose anti-Israel stance and lack of economic knowledge threaten the city's large Israeli-founded tech sector. He reveals that a World Health Organization official admitted that promoting "famine" in Gaza was a deliberate communications and political pressure strategy, despite adequate food supply. Hoenlein confirms that Hezbollah is rearming and refashioning ordnance in Lebanon, forcing Israel's hand. University leaders have begun acknowledging that campus unrest was largely foreign-driven, specifically citing Iran. Indonesia is noted as a potential key player in future Abraham Accords. 1015-1030 NYC Election, Famine Propaganda, and Foreign Influence on Campus. Malcolm Hoenlein discusses the New York City mayoral election, focusing on the populist rise of candidate Zelldin Maamoun, whose anti-Israel stance and lack of economic knowledge threaten the city's large Israeli-founded tech sector. He reveals that a World Health Organization official admitted that promoting "famine" in Gaza was a deliberate communications and political pressure strategy, despite adequate food supply. Hoenlein confirms that Hezbollah is rearming and refashioning ordnance in Lebanon, forcing Israel's hand. University leaders have begun acknowledging that campus unrest was largely foreign-driven, specifically citing Iran. Indonesia is noted as a potential key player in future Abraham Accords. 1030-1045 US Military Buildup Near Venezuela and Opposition Support for Action. Ernesto Araújo and Alejandro Peña Esclusa discuss the unprecedented US military buildup at the former Roosevelt Roads Naval Base in Puerto Rico, interpreted as preparations for action against Venezuela. Peña Esclusa clarifies that the true Venezuelan opposition, led by María Corina Machado (who won 93% of the primary vote), supports US action against the Maduro drug cartel. Araújo asserts that this is viewed regionally as a "crusade against organized crime," not an invasion, and would be welcomed by people tired of instability. This credible threat is already pressuring Venezuelan military officials to negotiate Maduro's exiIT. 1045-1100 US Military Buildup Near Venezuela and Opposition Support for Action. Ernesto Araújo and Alejandro Peña Esclusa discuss the unprecedented US military buildup at the former Roosevelt Roads Naval Base in Puerto Rico, interpreted as preparations for action against Venezuela. Peña Esclusa clarifies that the true Venezuelan opposition, led by María Corina Machado (who won 93% of the primary vote), supports US action against the Maduro drug cartel. Araújo asserts that this is viewed regionally as a "crusade against organized crime," not an invasion, and would be welcomed by people tired of instability. This credible threat is already pressuring Venezuelan military officials to negotiate Maduro's exiIT.THIRD HOUR 1100-1115 Russia's New Glide Bombs and Ukraine's Battlefield Crisis at Kurakhove. John Hardie and Bill Roggio discuss how Russia has introduced new, longer-range guided glide bombs (like the UMPK and Grom-E1) that utilize cheap kits or purpose-built designs, offering a cost-effective, more survivable standoff weapon to attack critical infrastructure deep inside Ukraine. Meanwhile, the situation in the key logistics hub of Kurakhove is deteriorating, with Russian infantry infiltrating the city, disrupting crucial drone and mortar positions, and threatening to encircle remaining Ukrainian forces. Russia continues to maintain maximalist peace demands, including a ban on Ukraine joining NATO and demilitarization, resulting in the cancellation of proposed peace talks. 1115-1130 Russia's New Glide Bombs and Ukraine's Battlefield Crisis at Kurakhove. John Hardie and Bill Roggio discuss how Russia has introduced new, longer-range guided glide bombs (like the UMPK and Grom-E1) that utilize cheap kits or purpose-built designs, offering a cost-effective, more survivable standoff weapon to attack critical infrastructure deep inside Ukraine. Meanwhile, the situation in the key logistics hub of Kurakhove is deteriorating, with Russian infantry infiltrating the city, disrupting crucial drone and mortar positions, and threatening to encircle remaining Ukrainian forces. Russia continues to maintain maximalist peace demands, including a ban on Ukraine joining NATO and demilitarization, resulting in the cancellation of proposed peace talks. 1130-1145 Supreme Court, Trade Tariffs, and the Stagnant Order. Alan Tonelson discusses a Supreme Court case challenging the president's tariff powers (the "Liberation Day tariffs"), which he expects the administration to win. Tonelson cites historical deference to presidential foreign policy power and the president's authority to use other well-established tariffing measures, calling arguments against his powers "legally ignorant." The conversation also explores Michael Beckley's theory of a "stagnant order" among superpowers, leading them to act parasitically or defensively. Tonelson disagrees with the stagnation premise for the US, anticipating a major productivity boom thanks to artificial intelligence. 1145-1200 Supreme Court, Trade Tariffs, and the Stagnant Order. Alan Tonelson discusses a Supreme Court case challenging the president's tariff powers (the "Liberation Day tariffs"), which he expects the administration to win. Tonelson cites historical deference to presidential foreign policy power and the president's authority to use other well-established tariffing measures, calling arguments against his powers "legally ignorant." The conversation also explores Michael Beckley's theory of a "stagnant order" among superpowers, leading them to act parasitically or defensively. Tonelson disagrees with the stagnation premise for the US, anticipating a major productivity boom thanks to artificial intelligence. FOURTH HOUR 12-1215 AI Revolution, Cloud Growth, and the Virtual Cell. Brandon Weichert reports on how AI is driving massive growth in cloud computing, exemplified by Amazon's surging shares and AWS growth, reaching paces "we haven't seen since 2022." Weichert dismisses fears of an "AI crash" as fear-mongering rooted in ignorance and past market bubbles, arguing that AI is sparking new sectors and enhancing productivity across industries. He details the cutting-edge application of AI in creating a "virtual cell"—computer models that simulate cell functions to speed up drug discovery, understand disease mechanisms, and inform scientific investigation. 1215-1230 Iran's Contradictory Nuclear Signals and Proxy Support. Jonathan Schanzer and Bill Roggio discuss how Iran is sending contradictory messages regarding its nuclear enrichment program and negotiations, with President Pezeshkian ("the dove") threatening to restart enrichment. Schanzer explains that "reformists" like Pezeshkian serve as a calculated front to signal openness while building leverage for future talks. Iran appears willing to risk future strikes, believing it can absorb them. However, Iran's ability to significantly rebuild its air defenses is complicated by the risk of UN snapback sanctions potentially deterring Russia and China from supplying advanced systems. Sanctions relief remains a key factor in Iran's proxy support. 1230-1245 UNIFIL's Failure, Hezbollah's Rebuilding, and Syria's Fragmented Future. Edmund Fitton-Brown, Ahmad Sharawi, and Bill Roggio label the UN Interim Force in Lebanon (UNIFIL) a "spectacular failure" that allowed Hezbollah's military buildup near the Israeli border. Despite the ceasefire terms requiring demilitarization south of the Litani River, the Lebanese government is stalling. Hezbollah is actively rebuilding its infrastructure, forcing Israel to conduct targeted enforcement actions. They also discuss Syrian President Ahmad al-Sharaa, who is seeking international legitimacy, sanctions relief, and partners to counter ISIS, even as his state remains domestically fragmented by regional demands for separation or autonomy. 1245-100 AM UNIFIL's Failure, Hezbollah's Rebuilding, and Syria's Fragmented Future. Edmund Fitton-Brown, Ahmad Sharawi, and Bill Roggio label the UN Interim Force in Lebanon (UNIFIL) a "spectacular failure" that allowed Hezbollah's military buildup near the Israeli border. Despite the ceasefire terms requiring demilitarization south of the Litani River, the Lebanese government is stalling. Hezbollah is actively rebuilding its infrastructure, forcing Israel to conduct targeted enforcement actions. They also discuss Syrian President Ahmad al-Sharaa, who is seeking international legitimacy, sanctions relief, and partners to counter ISIS, even as his state remains domestically fragmented by regional demands for separation or autonomy.